5 Top Stocks Cathie Wood Bought This Week

InvestorPlace2022-07-22

Cathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

291

Report

Comment（60）

Barbarazhao
·2022-07-22
Ok
Reply
Like
Report
Ahsiang
·2022-07-22
Omg
Reply
Like
Report
RL7741
·2022-07-22
Good sharing[Smile]
Reply
3
Report
Jyozu
·2022-07-22
Ok
Reply
1
Report
XiaTian
·2022-07-22
Okay
Reply
1
Report
MamaLee
·2022-07-22
Ok
Reply
1
Report
Patjaslyn
·2022-07-22
Ok
Reply
1
Report
jjt87
·2022-07-22
Ok
Reply
3
Report
Hi001
·2022-07-22
Ok
Reply
11
Report
nxw
·2022-07-22
Like pls
Reply
8
Report
och
·2022-07-22
K
Reply
9
Report
KhimTan
·2022-07-22
K
Reply
6
Report
KhimTan
·2022-07-22
K
Reply
5
Report
sinoob
·2022-07-22
Tgif!!! Come like like comment comment tqtq kamsahamida arigato
Reply
5
Report
jejesss
·2022-07-22
Ok
Reply
6
Report
NP_YT
·2022-07-22
Ok
Reply
5
Report
yingyingzoe
·2022-07-22
K
Reply
3
Report
Sonny111
·2022-07-22
Expert in selling low and buying high. Hopefully she is right this time.. ha ha😅😅
Reply
4
Report
kkennn
·2022-07-22
Okk
Reply
4
Report
nummiebuddy
·2022-07-22
Ok
Reply
3
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1167504690?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-07-22 09:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1167504690","market":"us","top_or_hot":-1,"title":"5 Top Stocks Cathie Wood Bought This Week","media":"InvestorPlace","content":"<div>\nCathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ...\n\n<a href=\"https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/\">Source Link</a>\n\n</div>\n","source":"lsy1606302653667","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Top Stocks Cathie Wood Bought This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Top Stocks Cathie Wood Bought This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-07-22 09:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nCathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ...\n\n<a href=\"https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TER","symbol_name":"泰瑞达","start_time":0,"source_url":"https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/","article_id":"1167504690","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1167504690","pubTimestamp":1658454795,"sourceInfo":{"source_id":"lsy1606302653667","name":"InvestorPlace"},"weMediaInfo":null,"summary":"Cathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchase","collect":0,"end_time":0,"defaultTopTitle":"investorplace.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"TER":"泰瑞达","DNA":"Ginkgo Bioworks Holdings Inc.","TRMB":"天宝导航","TWST":"Twist Bioscience Corp","KTOS":"克瑞拓斯安全防卫"},"translate_title":"凯西·伍德本周买入的5只顶级股票","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DNA":0.9,"KTOS":0.9,"TER":0.9,"TRMB":0.9,"TWST":0.9},"content_text":"Cathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ARK Innovation ETF(ARKK), are down over 45% year-to-date.Shares of Cathie Wood’s flagship exchange-traded fund (ETF), the ARK Innovation ETF(NYSEARCA:ARKK), are up about 20% the past month. Despite the short term recovery, the ETF is still down more than 45% year-to-date. Cathie Wood stocks haven’t exactly beaten the market so far this year.In related news, the ARK Transparency ETF(BATS:CTRU) will officially be shutting down just eight months after its launch. However, the termination of the fund is not related to performance or a lack of popularity. Rather, the index that CTRU tracks, The Transparency Index, will cease to calculate performance at the end of the month. Ark Investstated that it had failed to find an alternative index to track. CTRU will close on July 26, or “as soon as practical thereafter.” This will be Ark’s first ever fund-closure.With that in mind, let’s take a look at five stocks that Cathie Wood bought this week.5 Top Stocks Cathie Wood Bought This Week1.Kratos Defense & Security Solutions(KTOS)Kratos(NASDAQ:KTOS) operates as a national security company that develops weapons and communication and cybersecurity services for the U.S. and its allies. Unlike many other companies who are cutting their workforce, Kratos recently announced additional job openings at its facility in Birmingham, Alabama. The company also announced that it will invest $8.6 million at its Birmingham facility over the next five years. This investment will support advancements in hypersonic technology.From July 18 to July 20, Wood purchased219,011 shares of KTOS through two of her ETFs. After the purchases, Ark Invest now owns a total of 9.96 million shares.2.Teradyne(TER)Teradyne(NASDAQ:TER) is an automatic test equipment designer that serves customers such as Intel(NASDAQ:INTC) and Qualcomm(NASDAQ:QCOM). The company helps customers automate two key aspects of manufacturing: task automation and electronic testing. The company’s task automation process utilizes collaborative robots to help automate tasks and deliver a fast return on investment (ROI). The electronics testing process helps companies reduce the time-to-market for products using automated test equipment (ATE).From July 18 to July 20, Wood purchased53,822 shares of TER through two of her ETFs. Ark Invest now owns a total of 497,048 shares.3. Ginkgo Bioworks(DNA)Ginkgo Bioworks(NYSE:DNA) is one of the few companies that Wood has been relentlessly buying through ARKK and the ARK Genomic Revolution ETF(BATS:ARKG). On July 18, the two ETFs scooped up a total of1.15 million shares. After the purchases, Ark Invest owns a total of 86.41 million shares, making it a top ten shareholder. Across all Ark ETFs, DNA is currently the 19th largest position with a 1.63% allocation.Ginkgo is a biotech company that specializes in genetic engineering. The company is involved with programming cells in a multitude of industries, ranging from food to therapeutics. This week, Ginkgo announced acollaborationwithSumitomoChemicals, a leading chemical company in Japan. Sumitomo will leverage Ginkgo’s engineering expertise and codebase to help improve products in several industries, such as the beauty and personal care industry.4.Trimble(TRMB)Trimble(NASDAQ:TRMB) provides software and hardware solutions across a variety of industries. The company employs workers in over 40 countries, while its solutions are used in over 150 countries. Additionally, TRMB carries an average price target of $88.29among seven firms with coverage of the stock. This implies upside of more than 35% from current price levels.From July 18 to July 20, Ark Invest purchased 70,734 shares of TRMB through two of its ETFs. This marks a major shift in trend, as Ark only sold shares of Trimble between Dec. 27 and May 2. After the purchases, Ark owns a total of 2.22 million shares.5. Twist Bioscience(TWST)Twist Bioscience(NASDAQ:TWST) is a DNA synthesis company that offers DNA products to customers in several industries. The company developed a proprietary synthetic DNA manufacturing process that allows it to “minimize” the chemistry used for DNA synthesis. The miniaturization allows Twist to “reduce the reaction volumes by a factor of 1,000,000 while increasing throughput by a factor of 1,000.” As a result, Twist’s DNA process translates into time and cost savings for its customers.On July 18, ARKK and ARKG purchased a total of 39,624 shares of TWST. After the purchases, Ark now owns a total of 6.59 million shares, making it the second largest shareholder behind FMR.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9077192916,"gmtCreate":1658463405535,"gmtModify":1676536163719,"author":{"id":"3576888762442253","authorId":"3576888762442253","name":"Barbarazhao","avatar":"https://static.tigerbbs.com/40f6fdeabe0e8cac300f1fd2a17eb3ac","vip":1,"crmLevel":8,"crmLevelSwitch":1,"authorIdStr":"3576888762442253","idStr":"3576888762442253"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9077192916","repostId":1167504690,"repostType":4,"repost":{"id":"1167504690","pubTimestamp":1658454795,"share":"https://ttm.financial/m/news/1167504690?lang=&edition=fundamental","pubTime":"2022-07-22 09:53","market":"us","language":"en","title":"5 Top Stocks Cathie Wood Bought This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1167504690","media":"InvestorPlace","summary":"Cathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchase","content":"<html><head></head><body><ul><li>Cathie Wood&#39;s stock purchases have largely outnumbered her sales this week.</li><li>The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).</li><li>Shares of her flagship ETF, the ARK Innovation ETF(ARKK), are down over 45% year-to-date.</li></ul>Shares of Cathie Wood’s flagship exchange-traded fund (ETF), the ARK Innovation ETF(NYSEARCA:ARKK), are up about 20% the past month. Despite the short term recovery, the ETF is still down more than 45% year-to-date. Cathie Wood stocks haven’t exactly beaten the market so far this year.In related news, the ARK Transparency ETF(BATS:CTRU) will officially be shutting down just eight months after its launch. However, the termination of the fund is not related to performance or a lack of popularity. Rather, the index that CTRU tracks, The Transparency Index, will cease to calculate performance at the end of the month. Ark Investstated that it had failed to find an alternative index to track. CTRU will close on July 26, or “as soon as practical thereafter.” This will be Ark’s first ever fund-closure.With that in mind, let’s take a look at five stocks that Cathie Wood bought this week.5 Top Stocks Cathie Wood Bought This Week1.Kratos Defense &amp; Security Solutions(KTOS)Kratos(NASDAQ:KTOS) operates as a national security company that develops weapons and communication and cybersecurity services for the U.S. and its allies. Unlike many other companies who are cutting their workforce, Kratos recently announced additional job openings at its facility in Birmingham, Alabama. The company also announced that it will invest $8.6 million at its Birmingham facility over the next five years. This investment will support advancements in hypersonic technology.From July 18 to July 20, Wood purchased219,011 shares of KTOS through two of her ETFs. After the purchases, Ark Invest now owns a total of 9.96 million shares.2.Teradyne(TER)Teradyne(NASDAQ:TER) is an automatic test equipment designer that serves customers such as Intel(NASDAQ:INTC) and Qualcomm(NASDAQ:QCOM). The company helps customers automate two key aspects of manufacturing: task automation and electronic testing. The company’s task automation process utilizes collaborative robots to help automate tasks and deliver a fast return on investment (ROI). The electronics testing process helps companies reduce the time-to-market for products using automated test equipment (ATE).From July 18 to July 20, Wood purchased53,822 shares of TER through two of her ETFs. Ark Invest now owns a total of 497,048 shares.3. Ginkgo Bioworks(DNA)Ginkgo Bioworks(NYSE:DNA) is one of the few companies that Wood has been relentlessly buying through ARKK and the ARK Genomic Revolution ETF(BATS:ARKG). On July 18, the two ETFs scooped up a total of1.15 million shares. After the purchases, Ark Invest owns a total of 86.41 million shares, making it a top ten shareholder. Across all Ark ETFs, DNA is currently the 19th largest position with a 1.63% allocation.Ginkgo is a biotech company that specializes in genetic engineering. The company is involved with programming cells in a multitude of industries, ranging from food to therapeutics. This week, Ginkgo announced acollaborationwithSumitomoChemicals, a leading chemical company in Japan. Sumitomo will leverage Ginkgo’s engineering expertise and codebase to help improve products in several industries, such as the beauty and personal care industry.4.Trimble(TRMB)Trimble(NASDAQ:TRMB) provides software and hardware solutions across a variety of industries. The company employs workers in over 40 countries, while its solutions are used in over 150 countries. Additionally, TRMB carries an average price target of $88.29among seven firms with coverage of the stock. This implies upside of more than 35% from current price levels.From July 18 to July 20, Ark Invest purchased 70,734 shares of TRMB through two of its ETFs. This marks a major shift in trend, as Ark only sold shares of Trimble between Dec. 27 and May 2. After the purchases, Ark owns a total of 2.22 million shares.5. Twist Bioscience(TWST)Twist Bioscience(NASDAQ:TWST) is a DNA synthesis company that offers DNA products to customers in several industries. The company developed a proprietary synthetic DNA manufacturing process that allows it to “minimize” the chemistry used for DNA synthesis. The miniaturization allows Twist to “reduce the reaction volumes by a factor of 1,000,000 while increasing throughput by a factor of 1,000.” As a result, Twist’s DNA process translates into time and cost savings for its customers.On July 18, ARKK and ARKG purchased a total of 39,624 shares of TWST. After the purchases, Ark now owns a total of 6.59 million shares, making it the second largest shareholder behind FMR.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Top Stocks Cathie Wood Bought This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Top Stocks Cathie Wood Bought This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-07-22 09:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nCathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ...\n\n<a href=\"https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TWST":"Twist Bioscience Corp","TER":"泰瑞达","KTOS":"克瑞拓斯安全防卫","TRMB":"天宝导航","DNA":"Ginkgo Bioworks Holdings Inc."},"source_url":"https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167504690","content_text":"Cathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ARK Innovation ETF(ARKK), are down over 45% year-to-date.Shares of Cathie Wood’s flagship exchange-traded fund (ETF), the ARK Innovation ETF(NYSEARCA:ARKK), are up about 20% the past month. Despite the short term recovery, the ETF is still down more than 45% year-to-date. Cathie Wood stocks haven’t exactly beaten the market so far this year.In related news, the ARK Transparency ETF(BATS:CTRU) will officially be shutting down just eight months after its launch. However, the termination of the fund is not related to performance or a lack of popularity. Rather, the index that CTRU tracks, The Transparency Index, will cease to calculate performance at the end of the month. Ark Investstated that it had failed to find an alternative index to track. CTRU will close on July 26, or “as soon as practical thereafter.” This will be Ark’s first ever fund-closure.With that in mind, let’s take a look at five stocks that Cathie Wood bought this week.5 Top Stocks Cathie Wood Bought This Week1.Kratos Defense & Security Solutions(KTOS)Kratos(NASDAQ:KTOS) operates as a national security company that develops weapons and communication and cybersecurity services for the U.S. and its allies. Unlike many other companies who are cutting their workforce, Kratos recently announced additional job openings at its facility in Birmingham, Alabama. The company also announced that it will invest $8.6 million at its Birmingham facility over the next five years. This investment will support advancements in hypersonic technology.From July 18 to July 20, Wood purchased219,011 shares of KTOS through two of her ETFs. After the purchases, Ark Invest now owns a total of 9.96 million shares.2.Teradyne(TER)Teradyne(NASDAQ:TER) is an automatic test equipment designer that serves customers such as Intel(NASDAQ:INTC) and Qualcomm(NASDAQ:QCOM). The company helps customers automate two key aspects of manufacturing: task automation and electronic testing. The company’s task automation process utilizes collaborative robots to help automate tasks and deliver a fast return on investment (ROI). The electronics testing process helps companies reduce the time-to-market for products using automated test equipment (ATE).From July 18 to July 20, Wood purchased53,822 shares of TER through two of her ETFs. Ark Invest now owns a total of 497,048 shares.3. Ginkgo Bioworks(DNA)Ginkgo Bioworks(NYSE:DNA) is one of the few companies that Wood has been relentlessly buying through ARKK and the ARK Genomic Revolution ETF(BATS:ARKG). On July 18, the two ETFs scooped up a total of1.15 million shares. After the purchases, Ark Invest owns a total of 86.41 million shares, making it a top ten shareholder. Across all Ark ETFs, DNA is currently the 19th largest position with a 1.63% allocation.Ginkgo is a biotech company that specializes in genetic engineering. The company is involved with programming cells in a multitude of industries, ranging from food to therapeutics. This week, Ginkgo announced acollaborationwithSumitomoChemicals, a leading chemical company in Japan. Sumitomo will leverage Ginkgo’s engineering expertise and codebase to help improve products in several industries, such as the beauty and personal care industry.4.Trimble(TRMB)Trimble(NASDAQ:TRMB) provides software and hardware solutions across a variety of industries. The company employs workers in over 40 countries, while its solutions are used in over 150 countries. Additionally, TRMB carries an average price target of $88.29among seven firms with coverage of the stock. This implies upside of more than 35% from current price levels.From July 18 to July 20, Ark Invest purchased 70,734 shares of TRMB through two of its ETFs. This marks a major shift in trend, as Ark only sold shares of Trimble between Dec. 27 and May 2. After the purchases, Ark owns a total of 2.22 million shares.5. Twist Bioscience(TWST)Twist Bioscience(NASDAQ:TWST) is a DNA synthesis company that offers DNA products to customers in several industries. The company developed a proprietary synthetic DNA manufacturing process that allows it to “minimize” the chemistry used for DNA synthesis. The miniaturization allows Twist to “reduce the reaction volumes by a factor of 1,000,000 while increasing throughput by a factor of 1,000.” As a result, Twist’s DNA process translates into time and cost savings for its customers.On July 18, ARKK and ARKG purchased a total of 39,624 shares of TWST. After the purchases, Ark now owns a total of 6.59 million shares, making it the second largest shareholder behind FMR.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9077101797,"gmtCreate":1658461815419,"gmtModify":1676536163428,"author":{"id":"3582617881962608","authorId":"3582617881962608","name":"Ahsiang","avatar":"https://static.tigerbbs.com/310f96e7696af85ae33ece774a483d15","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3582617881962608","idStr":"3582617881962608"},"htmlText":"Omg","listText":"Omg","text":"Omg","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9077101797","repostId":1167504690,"repostType":4,"repost":{"id":"1167504690","pubTimestamp":1658454795,"share":"https://ttm.financial/m/news/1167504690?lang=&edition=fundamental","pubTime":"2022-07-22 09:53","market":"us","language":"en","title":"5 Top Stocks Cathie Wood Bought This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1167504690","media":"InvestorPlace","summary":"Cathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchase","content":"<html><head></head><body><ul><li>Cathie Wood&#39;s stock purchases have largely outnumbered her sales this week.</li><li>The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).</li><li>Shares of her flagship ETF, the ARK Innovation ETF(ARKK), are down over 45% year-to-date.</li></ul>Shares of Cathie Wood’s flagship exchange-traded fund (ETF), the ARK Innovation ETF(NYSEARCA:ARKK), are up about 20% the past month. Despite the short term recovery, the ETF is still down more than 45% year-to-date. Cathie Wood stocks haven’t exactly beaten the market so far this year.In related news, the ARK Transparency ETF(BATS:CTRU) will officially be shutting down just eight months after its launch. However, the termination of the fund is not related to performance or a lack of popularity. Rather, the index that CTRU tracks, The Transparency Index, will cease to calculate performance at the end of the month. Ark Investstated that it had failed to find an alternative index to track. CTRU will close on July 26, or “as soon as practical thereafter.” This will be Ark’s first ever fund-closure.With that in mind, let’s take a look at five stocks that Cathie Wood bought this week.5 Top Stocks Cathie Wood Bought This Week1.Kratos Defense &amp; Security Solutions(KTOS)Kratos(NASDAQ:KTOS) operates as a national security company that develops weapons and communication and cybersecurity services for the U.S. and its allies. Unlike many other companies who are cutting their workforce, Kratos recently announced additional job openings at its facility in Birmingham, Alabama. The company also announced that it will invest $8.6 million at its Birmingham facility over the next five years. This investment will support advancements in hypersonic technology.From July 18 to July 20, Wood purchased219,011 shares of KTOS through two of her ETFs. After the purchases, Ark Invest now owns a total of 9.96 million shares.2.Teradyne(TER)Teradyne(NASDAQ:TER) is an automatic test equipment designer that serves customers such as Intel(NASDAQ:INTC) and Qualcomm(NASDAQ:QCOM). The company helps customers automate two key aspects of manufacturing: task automation and electronic testing. The company’s task automation process utilizes collaborative robots to help automate tasks and deliver a fast return on investment (ROI). The electronics testing process helps companies reduce the time-to-market for products using automated test equipment (ATE).From July 18 to July 20, Wood purchased53,822 shares of TER through two of her ETFs. Ark Invest now owns a total of 497,048 shares.3. Ginkgo Bioworks(DNA)Ginkgo Bioworks(NYSE:DNA) is one of the few companies that Wood has been relentlessly buying through ARKK and the ARK Genomic Revolution ETF(BATS:ARKG). On July 18, the two ETFs scooped up a total of1.15 million shares. After the purchases, Ark Invest owns a total of 86.41 million shares, making it a top ten shareholder. Across all Ark ETFs, DNA is currently the 19th largest position with a 1.63% allocation.Ginkgo is a biotech company that specializes in genetic engineering. The company is involved with programming cells in a multitude of industries, ranging from food to therapeutics. This week, Ginkgo announced acollaborationwithSumitomoChemicals, a leading chemical company in Japan. Sumitomo will leverage Ginkgo’s engineering expertise and codebase to help improve products in several industries, such as the beauty and personal care industry.4.Trimble(TRMB)Trimble(NASDAQ:TRMB) provides software and hardware solutions across a variety of industries. The company employs workers in over 40 countries, while its solutions are used in over 150 countries. Additionally, TRMB carries an average price target of $88.29among seven firms with coverage of the stock. This implies upside of more than 35% from current price levels.From July 18 to July 20, Ark Invest purchased 70,734 shares of TRMB through two of its ETFs. This marks a major shift in trend, as Ark only sold shares of Trimble between Dec. 27 and May 2. After the purchases, Ark owns a total of 2.22 million shares.5. Twist Bioscience(TWST)Twist Bioscience(NASDAQ:TWST) is a DNA synthesis company that offers DNA products to customers in several industries. The company developed a proprietary synthetic DNA manufacturing process that allows it to “minimize” the chemistry used for DNA synthesis. The miniaturization allows Twist to “reduce the reaction volumes by a factor of 1,000,000 while increasing throughput by a factor of 1,000.” As a result, Twist’s DNA process translates into time and cost savings for its customers.On July 18, ARKK and ARKG purchased a total of 39,624 shares of TWST. After the purchases, Ark now owns a total of 6.59 million shares, making it the second largest shareholder behind FMR.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Top Stocks Cathie Wood Bought This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Top Stocks Cathie Wood Bought This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-07-22 09:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nCathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ...\n\n<a href=\"https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TWST":"Twist Bioscience Corp","TER":"泰瑞达","KTOS":"克瑞拓斯安全防卫","TRMB":"天宝导航","DNA":"Ginkgo Bioworks Holdings Inc."},"source_url":"https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167504690","content_text":"Cathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ARK Innovation ETF(ARKK), are down over 45% year-to-date.Shares of Cathie Wood’s flagship exchange-traded fund (ETF), the ARK Innovation ETF(NYSEARCA:ARKK), are up about 20% the past month. Despite the short term recovery, the ETF is still down more than 45% year-to-date. Cathie Wood stocks haven’t exactly beaten the market so far this year.In related news, the ARK Transparency ETF(BATS:CTRU) will officially be shutting down just eight months after its launch. However, the termination of the fund is not related to performance or a lack of popularity. Rather, the index that CTRU tracks, The Transparency Index, will cease to calculate performance at the end of the month. Ark Investstated that it had failed to find an alternative index to track. CTRU will close on July 26, or “as soon as practical thereafter.” This will be Ark’s first ever fund-closure.With that in mind, let’s take a look at five stocks that Cathie Wood bought this week.5 Top Stocks Cathie Wood Bought This Week1.Kratos Defense & Security Solutions(KTOS)Kratos(NASDAQ:KTOS) operates as a national security company that develops weapons and communication and cybersecurity services for the U.S. and its allies. Unlike many other companies who are cutting their workforce, Kratos recently announced additional job openings at its facility in Birmingham, Alabama. The company also announced that it will invest $8.6 million at its Birmingham facility over the next five years. This investment will support advancements in hypersonic technology.From July 18 to July 20, Wood purchased219,011 shares of KTOS through two of her ETFs. After the purchases, Ark Invest now owns a total of 9.96 million shares.2.Teradyne(TER)Teradyne(NASDAQ:TER) is an automatic test equipment designer that serves customers such as Intel(NASDAQ:INTC) and Qualcomm(NASDAQ:QCOM). The company helps customers automate two key aspects of manufacturing: task automation and electronic testing. The company’s task automation process utilizes collaborative robots to help automate tasks and deliver a fast return on investment (ROI). The electronics testing process helps companies reduce the time-to-market for products using automated test equipment (ATE).From July 18 to July 20, Wood purchased53,822 shares of TER through two of her ETFs. Ark Invest now owns a total of 497,048 shares.3. Ginkgo Bioworks(DNA)Ginkgo Bioworks(NYSE:DNA) is one of the few companies that Wood has been relentlessly buying through ARKK and the ARK Genomic Revolution ETF(BATS:ARKG). On July 18, the two ETFs scooped up a total of1.15 million shares. After the purchases, Ark Invest owns a total of 86.41 million shares, making it a top ten shareholder. Across all Ark ETFs, DNA is currently the 19th largest position with a 1.63% allocation.Ginkgo is a biotech company that specializes in genetic engineering. The company is involved with programming cells in a multitude of industries, ranging from food to therapeutics. This week, Ginkgo announced acollaborationwithSumitomoChemicals, a leading chemical company in Japan. Sumitomo will leverage Ginkgo’s engineering expertise and codebase to help improve products in several industries, such as the beauty and personal care industry.4.Trimble(TRMB)Trimble(NASDAQ:TRMB) provides software and hardware solutions across a variety of industries. The company employs workers in over 40 countries, while its solutions are used in over 150 countries. Additionally, TRMB carries an average price target of $88.29among seven firms with coverage of the stock. This implies upside of more than 35% from current price levels.From July 18 to July 20, Ark Invest purchased 70,734 shares of TRMB through two of its ETFs. This marks a major shift in trend, as Ark only sold shares of Trimble between Dec. 27 and May 2. After the purchases, Ark owns a total of 2.22 million shares.5. Twist Bioscience(TWST)Twist Bioscience(NASDAQ:TWST) is a DNA synthesis company that offers DNA products to customers in several industries. The company developed a proprietary synthetic DNA manufacturing process that allows it to “minimize” the chemistry used for DNA synthesis. The miniaturization allows Twist to “reduce the reaction volumes by a factor of 1,000,000 while increasing throughput by a factor of 1,000.” As a result, Twist’s DNA process translates into time and cost savings for its customers.On July 18, ARKK and ARKG purchased a total of 39,624 shares of TWST. After the purchases, Ark now owns a total of 6.59 million shares, making it the second largest shareholder behind FMR.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9077377966,"gmtCreate":1658460996855,"gmtModify":1676536163307,"author":{"id":"3585382015740768","authorId":"3585382015740768","name":"RL7741","avatar":"https://community-static.tradeup.com/news/cc534d52d2b9325d1a2e19f4cf928bc2","vip":1,"crmLevel":4,"crmLevelSwitch":1,"authorIdStr":"3585382015740768","idStr":"3585382015740768"},"htmlText":"Good sharing[Smile]&nbsp;","listText":"Good sharing[Smile]&nbsp;","text":"Good sharing[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9077377966","repostId":1167504690,"repostType":4,"repost":{"id":"1167504690","pubTimestamp":1658454795,"share":"https://ttm.financial/m/news/1167504690?lang=&edition=fundamental","pubTime":"2022-07-22 09:53","market":"us","language":"en","title":"5 Top Stocks Cathie Wood Bought This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1167504690","media":"InvestorPlace","summary":"Cathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchase","content":"<html><head></head><body><ul><li>Cathie Wood&#39;s stock purchases have largely outnumbered her sales this week.</li><li>The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).</li><li>Shares of her flagship ETF, the ARK Innovation ETF(ARKK), are down over 45% year-to-date.</li></ul>Shares of Cathie Wood’s flagship exchange-traded fund (ETF), the ARK Innovation ETF(NYSEARCA:ARKK), are up about 20% the past month. Despite the short term recovery, the ETF is still down more than 45% year-to-date. Cathie Wood stocks haven’t exactly beaten the market so far this year.In related news, the ARK Transparency ETF(BATS:CTRU) will officially be shutting down just eight months after its launch. However, the termination of the fund is not related to performance or a lack of popularity. Rather, the index that CTRU tracks, The Transparency Index, will cease to calculate performance at the end of the month. Ark Investstated that it had failed to find an alternative index to track. CTRU will close on July 26, or “as soon as practical thereafter.” This will be Ark’s first ever fund-closure.With that in mind, let’s take a look at five stocks that Cathie Wood bought this week.5 Top Stocks Cathie Wood Bought This Week1.Kratos Defense &amp; Security Solutions(KTOS)Kratos(NASDAQ:KTOS) operates as a national security company that develops weapons and communication and cybersecurity services for the U.S. and its allies. Unlike many other companies who are cutting their workforce, Kratos recently announced additional job openings at its facility in Birmingham, Alabama. The company also announced that it will invest $8.6 million at its Birmingham facility over the next five years. This investment will support advancements in hypersonic technology.From July 18 to July 20, Wood purchased219,011 shares of KTOS through two of her ETFs. After the purchases, Ark Invest now owns a total of 9.96 million shares.2.Teradyne(TER)Teradyne(NASDAQ:TER) is an automatic test equipment designer that serves customers such as Intel(NASDAQ:INTC) and Qualcomm(NASDAQ:QCOM). The company helps customers automate two key aspects of manufacturing: task automation and electronic testing. The company’s task automation process utilizes collaborative robots to help automate tasks and deliver a fast return on investment (ROI). The electronics testing process helps companies reduce the time-to-market for products using automated test equipment (ATE).From July 18 to July 20, Wood purchased53,822 shares of TER through two of her ETFs. Ark Invest now owns a total of 497,048 shares.3. Ginkgo Bioworks(DNA)Ginkgo Bioworks(NYSE:DNA) is one of the few companies that Wood has been relentlessly buying through ARKK and the ARK Genomic Revolution ETF(BATS:ARKG). On July 18, the two ETFs scooped up a total of1.15 million shares. After the purchases, Ark Invest owns a total of 86.41 million shares, making it a top ten shareholder. Across all Ark ETFs, DNA is currently the 19th largest position with a 1.63% allocation.Ginkgo is a biotech company that specializes in genetic engineering. The company is involved with programming cells in a multitude of industries, ranging from food to therapeutics. This week, Ginkgo announced acollaborationwithSumitomoChemicals, a leading chemical company in Japan. Sumitomo will leverage Ginkgo’s engineering expertise and codebase to help improve products in several industries, such as the beauty and personal care industry.4.Trimble(TRMB)Trimble(NASDAQ:TRMB) provides software and hardware solutions across a variety of industries. The company employs workers in over 40 countries, while its solutions are used in over 150 countries. Additionally, TRMB carries an average price target of $88.29among seven firms with coverage of the stock. This implies upside of more than 35% from current price levels.From July 18 to July 20, Ark Invest purchased 70,734 shares of TRMB through two of its ETFs. This marks a major shift in trend, as Ark only sold shares of Trimble between Dec. 27 and May 2. After the purchases, Ark owns a total of 2.22 million shares.5. Twist Bioscience(TWST)Twist Bioscience(NASDAQ:TWST) is a DNA synthesis company that offers DNA products to customers in several industries. The company developed a proprietary synthetic DNA manufacturing process that allows it to “minimize” the chemistry used for DNA synthesis. The miniaturization allows Twist to “reduce the reaction volumes by a factor of 1,000,000 while increasing throughput by a factor of 1,000.” As a result, Twist’s DNA process translates into time and cost savings for its customers.On July 18, ARKK and ARKG purchased a total of 39,624 shares of TWST. After the purchases, Ark now owns a total of 6.59 million shares, making it the second largest shareholder behind FMR.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Top Stocks Cathie Wood Bought This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Top Stocks Cathie Wood Bought This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-07-22 09:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nCathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ...\n\n<a href=\"https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TWST":"Twist Bioscience Corp","TER":"泰瑞达","KTOS":"克瑞拓斯安全防卫","TRMB":"天宝导航","DNA":"Ginkgo Bioworks Holdings Inc."},"source_url":"https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167504690","content_text":"Cathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ARK Innovation ETF(ARKK), are down over 45% year-to-date.Shares of Cathie Wood’s flagship exchange-traded fund (ETF), the ARK Innovation ETF(NYSEARCA:ARKK), are up about 20% the past month. Despite the short term recovery, the ETF is still down more than 45% year-to-date. Cathie Wood stocks haven’t exactly beaten the market so far this year.In related news, the ARK Transparency ETF(BATS:CTRU) will officially be shutting down just eight months after its launch. However, the termination of the fund is not related to performance or a lack of popularity. Rather, the index that CTRU tracks, The Transparency Index, will cease to calculate performance at the end of the month. Ark Investstated that it had failed to find an alternative index to track. CTRU will close on July 26, or “as soon as practical thereafter.” This will be Ark’s first ever fund-closure.With that in mind, let’s take a look at five stocks that Cathie Wood bought this week.5 Top Stocks Cathie Wood Bought This Week1.Kratos Defense & Security Solutions(KTOS)Kratos(NASDAQ:KTOS) operates as a national security company that develops weapons and communication and cybersecurity services for the U.S. and its allies. Unlike many other companies who are cutting their workforce, Kratos recently announced additional job openings at its facility in Birmingham, Alabama. The company also announced that it will invest $8.6 million at its Birmingham facility over the next five years. This investment will support advancements in hypersonic technology.From July 18 to July 20, Wood purchased219,011 shares of KTOS through two of her ETFs. After the purchases, Ark Invest now owns a total of 9.96 million shares.2.Teradyne(TER)Teradyne(NASDAQ:TER) is an automatic test equipment designer that serves customers such as Intel(NASDAQ:INTC) and Qualcomm(NASDAQ:QCOM). The company helps customers automate two key aspects of manufacturing: task automation and electronic testing. The company’s task automation process utilizes collaborative robots to help automate tasks and deliver a fast return on investment (ROI). The electronics testing process helps companies reduce the time-to-market for products using automated test equipment (ATE).From July 18 to July 20, Wood purchased53,822 shares of TER through two of her ETFs. Ark Invest now owns a total of 497,048 shares.3. Ginkgo Bioworks(DNA)Ginkgo Bioworks(NYSE:DNA) is one of the few companies that Wood has been relentlessly buying through ARKK and the ARK Genomic Revolution ETF(BATS:ARKG). On July 18, the two ETFs scooped up a total of1.15 million shares. After the purchases, Ark Invest owns a total of 86.41 million shares, making it a top ten shareholder. Across all Ark ETFs, DNA is currently the 19th largest position with a 1.63% allocation.Ginkgo is a biotech company that specializes in genetic engineering. The company is involved with programming cells in a multitude of industries, ranging from food to therapeutics. This week, Ginkgo announced acollaborationwithSumitomoChemicals, a leading chemical company in Japan. Sumitomo will leverage Ginkgo’s engineering expertise and codebase to help improve products in several industries, such as the beauty and personal care industry.4.Trimble(TRMB)Trimble(NASDAQ:TRMB) provides software and hardware solutions across a variety of industries. The company employs workers in over 40 countries, while its solutions are used in over 150 countries. Additionally, TRMB carries an average price target of $88.29among seven firms with coverage of the stock. This implies upside of more than 35% from current price levels.From July 18 to July 20, Ark Invest purchased 70,734 shares of TRMB through two of its ETFs. This marks a major shift in trend, as Ark only sold shares of Trimble between Dec. 27 and May 2. After the purchases, Ark owns a total of 2.22 million shares.5. Twist Bioscience(TWST)Twist Bioscience(NASDAQ:TWST) is a DNA synthesis company that offers DNA products to customers in several industries. The company developed a proprietary synthetic DNA manufacturing process that allows it to “minimize” the chemistry used for DNA synthesis. The miniaturization allows Twist to “reduce the reaction volumes by a factor of 1,000,000 while increasing throughput by a factor of 1,000.” As a result, Twist’s DNA process translates into time and cost savings for its customers.On July 18, ARKK and ARKG purchased a total of 39,624 shares of TWST. After the purchases, Ark now owns a total of 6.59 million shares, making it the second largest shareholder behind FMR.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9077373593,"gmtCreate":1658460068312,"gmtModify":1676536163157,"author":{"id":"3585370461477110","authorId":"3585370461477110","name":"Jyozu","avatar":"https://static.tigerbbs.com/ac83cb007e9144d9710ce08e1d562f3b","vip":1,"hat":"https://static.tigerbbs.com/a3dee1aa3a3a3c1814833a4d3f8a5669","crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3585370461477110","idStr":"3585370461477110"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9077373593","repostId":1167504690,"repostType":4,"repost":{"id":"1167504690","pubTimestamp":1658454795,"share":"https://ttm.financial/m/news/1167504690?lang=&edition=fundamental","pubTime":"2022-07-22 09:53","market":"us","language":"en","title":"5 Top Stocks Cathie Wood Bought This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1167504690","media":"InvestorPlace","summary":"Cathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchase","content":"<html><head></head><body><ul><li>Cathie Wood&#39;s stock purchases have largely outnumbered her sales this week.</li><li>The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).</li><li>Shares of her flagship ETF, the ARK Innovation ETF(ARKK), are down over 45% year-to-date.</li></ul>Shares of Cathie Wood’s flagship exchange-traded fund (ETF), the ARK Innovation ETF(NYSEARCA:ARKK), are up about 20% the past month. Despite the short term recovery, the ETF is still down more than 45% year-to-date. Cathie Wood stocks haven’t exactly beaten the market so far this year.In related news, the ARK Transparency ETF(BATS:CTRU) will officially be shutting down just eight months after its launch. However, the termination of the fund is not related to performance or a lack of popularity. Rather, the index that CTRU tracks, The Transparency Index, will cease to calculate performance at the end of the month. Ark Investstated that it had failed to find an alternative index to track. CTRU will close on July 26, or “as soon as practical thereafter.” This will be Ark’s first ever fund-closure.With that in mind, let’s take a look at five stocks that Cathie Wood bought this week.5 Top Stocks Cathie Wood Bought This Week1.Kratos Defense &amp; Security Solutions(KTOS)Kratos(NASDAQ:KTOS) operates as a national security company that develops weapons and communication and cybersecurity services for the U.S. and its allies. Unlike many other companies who are cutting their workforce, Kratos recently announced additional job openings at its facility in Birmingham, Alabama. The company also announced that it will invest $8.6 million at its Birmingham facility over the next five years. This investment will support advancements in hypersonic technology.From July 18 to July 20, Wood purchased219,011 shares of KTOS through two of her ETFs. After the purchases, Ark Invest now owns a total of 9.96 million shares.2.Teradyne(TER)Teradyne(NASDAQ:TER) is an automatic test equipment designer that serves customers such as Intel(NASDAQ:INTC) and Qualcomm(NASDAQ:QCOM). The company helps customers automate two key aspects of manufacturing: task automation and electronic testing. The company’s task automation process utilizes collaborative robots to help automate tasks and deliver a fast return on investment (ROI). The electronics testing process helps companies reduce the time-to-market for products using automated test equipment (ATE).From July 18 to July 20, Wood purchased53,822 shares of TER through two of her ETFs. Ark Invest now owns a total of 497,048 shares.3. Ginkgo Bioworks(DNA)Ginkgo Bioworks(NYSE:DNA) is one of the few companies that Wood has been relentlessly buying through ARKK and the ARK Genomic Revolution ETF(BATS:ARKG). On July 18, the two ETFs scooped up a total of1.15 million shares. After the purchases, Ark Invest owns a total of 86.41 million shares, making it a top ten shareholder. Across all Ark ETFs, DNA is currently the 19th largest position with a 1.63% allocation.Ginkgo is a biotech company that specializes in genetic engineering. The company is involved with programming cells in a multitude of industries, ranging from food to therapeutics. This week, Ginkgo announced acollaborationwithSumitomoChemicals, a leading chemical company in Japan. Sumitomo will leverage Ginkgo’s engineering expertise and codebase to help improve products in several industries, such as the beauty and personal care industry.4.Trimble(TRMB)Trimble(NASDAQ:TRMB) provides software and hardware solutions across a variety of industries. The company employs workers in over 40 countries, while its solutions are used in over 150 countries. Additionally, TRMB carries an average price target of $88.29among seven firms with coverage of the stock. This implies upside of more than 35% from current price levels.From July 18 to July 20, Ark Invest purchased 70,734 shares of TRMB through two of its ETFs. This marks a major shift in trend, as Ark only sold shares of Trimble between Dec. 27 and May 2. After the purchases, Ark owns a total of 2.22 million shares.5. Twist Bioscience(TWST)Twist Bioscience(NASDAQ:TWST) is a DNA synthesis company that offers DNA products to customers in several industries. The company developed a proprietary synthetic DNA manufacturing process that allows it to “minimize” the chemistry used for DNA synthesis. The miniaturization allows Twist to “reduce the reaction volumes by a factor of 1,000,000 while increasing throughput by a factor of 1,000.” As a result, Twist’s DNA process translates into time and cost savings for its customers.On July 18, ARKK and ARKG purchased a total of 39,624 shares of TWST. After the purchases, Ark now owns a total of 6.59 million shares, making it the second largest shareholder behind FMR.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Top Stocks Cathie Wood Bought This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Top Stocks Cathie Wood Bought This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-07-22 09:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nCathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ...\n\n<a href=\"https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TWST":"Twist Bioscience Corp","TER":"泰瑞达","KTOS":"克瑞拓斯安全防卫","TRMB":"天宝导航","DNA":"Ginkgo Bioworks Holdings Inc."},"source_url":"https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167504690","content_text":"Cathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ARK Innovation ETF(ARKK), are down over 45% year-to-date.Shares of Cathie Wood’s flagship exchange-traded fund (ETF), the ARK Innovation ETF(NYSEARCA:ARKK), are up about 20% the past month. Despite the short term recovery, the ETF is still down more than 45% year-to-date. Cathie Wood stocks haven’t exactly beaten the market so far this year.In related news, the ARK Transparency ETF(BATS:CTRU) will officially be shutting down just eight months after its launch. However, the termination of the fund is not related to performance or a lack of popularity. Rather, the index that CTRU tracks, The Transparency Index, will cease to calculate performance at the end of the month. Ark Investstated that it had failed to find an alternative index to track. CTRU will close on July 26, or “as soon as practical thereafter.” This will be Ark’s first ever fund-closure.With that in mind, let’s take a look at five stocks that Cathie Wood bought this week.5 Top Stocks Cathie Wood Bought This Week1.Kratos Defense & Security Solutions(KTOS)Kratos(NASDAQ:KTOS) operates as a national security company that develops weapons and communication and cybersecurity services for the U.S. and its allies. Unlike many other companies who are cutting their workforce, Kratos recently announced additional job openings at its facility in Birmingham, Alabama. The company also announced that it will invest $8.6 million at its Birmingham facility over the next five years. This investment will support advancements in hypersonic technology.From July 18 to July 20, Wood purchased219,011 shares of KTOS through two of her ETFs. After the purchases, Ark Invest now owns a total of 9.96 million shares.2.Teradyne(TER)Teradyne(NASDAQ:TER) is an automatic test equipment designer that serves customers such as Intel(NASDAQ:INTC) and Qualcomm(NASDAQ:QCOM). The company helps customers automate two key aspects of manufacturing: task automation and electronic testing. The company’s task automation process utilizes collaborative robots to help automate tasks and deliver a fast return on investment (ROI). The electronics testing process helps companies reduce the time-to-market for products using automated test equipment (ATE).From July 18 to July 20, Wood purchased53,822 shares of TER through two of her ETFs. Ark Invest now owns a total of 497,048 shares.3. Ginkgo Bioworks(DNA)Ginkgo Bioworks(NYSE:DNA) is one of the few companies that Wood has been relentlessly buying through ARKK and the ARK Genomic Revolution ETF(BATS:ARKG). On July 18, the two ETFs scooped up a total of1.15 million shares. After the purchases, Ark Invest owns a total of 86.41 million shares, making it a top ten shareholder. Across all Ark ETFs, DNA is currently the 19th largest position with a 1.63% allocation.Ginkgo is a biotech company that specializes in genetic engineering. The company is involved with programming cells in a multitude of industries, ranging from food to therapeutics. This week, Ginkgo announced acollaborationwithSumitomoChemicals, a leading chemical company in Japan. Sumitomo will leverage Ginkgo’s engineering expertise and codebase to help improve products in several industries, such as the beauty and personal care industry.4.Trimble(TRMB)Trimble(NASDAQ:TRMB) provides software and hardware solutions across a variety of industries. The company employs workers in over 40 countries, while its solutions are used in over 150 countries. Additionally, TRMB carries an average price target of $88.29among seven firms with coverage of the stock. This implies upside of more than 35% from current price levels.From July 18 to July 20, Ark Invest purchased 70,734 shares of TRMB through two of its ETFs. This marks a major shift in trend, as Ark only sold shares of Trimble between Dec. 27 and May 2. After the purchases, Ark owns a total of 2.22 million shares.5. Twist Bioscience(TWST)Twist Bioscience(NASDAQ:TWST) is a DNA synthesis company that offers DNA products to customers in several industries. The company developed a proprietary synthetic DNA manufacturing process that allows it to “minimize” the chemistry used for DNA synthesis. The miniaturization allows Twist to “reduce the reaction volumes by a factor of 1,000,000 while increasing throughput by a factor of 1,000.” As a result, Twist’s DNA process translates into time and cost savings for its customers.On July 18, ARKK and ARKG purchased a total of 39,624 shares of TWST. After the purchases, Ark now owns a total of 6.59 million shares, making it the second largest shareholder behind FMR.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9077379648,"gmtCreate":1658459940884,"gmtModify":1676536163133,"author":{"id":"3575368380492738","authorId":"3575368380492738","name":"XiaTian","avatar":"https://community-static.tradeup.com/news/71777f1a5ae276e73064272b5ae7df92","vip":1,"crmLevel":3,"crmLevelSwitch":1,"authorIdStr":"3575368380492738","idStr":"3575368380492738"},"htmlText":"Okay&nbsp;","listText":"Okay&nbsp;","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9077379648","repostId":1167504690,"repostType":4,"repost":{"id":"1167504690","pubTimestamp":1658454795,"share":"https://ttm.financial/m/news/1167504690?lang=&edition=fundamental","pubTime":"2022-07-22 09:53","market":"us","language":"en","title":"5 Top Stocks Cathie Wood Bought This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1167504690","media":"InvestorPlace","summary":"Cathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchase","content":"<html><head></head><body><ul><li>Cathie Wood&#39;s stock purchases have largely outnumbered her sales this week.</li><li>The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).</li><li>Shares of her flagship ETF, the ARK Innovation ETF(ARKK), are down over 45% year-to-date.</li></ul>Shares of Cathie Wood’s flagship exchange-traded fund (ETF), the ARK Innovation ETF(NYSEARCA:ARKK), are up about 20% the past month. Despite the short term recovery, the ETF is still down more than 45% year-to-date. Cathie Wood stocks haven’t exactly beaten the market so far this year.In related news, the ARK Transparency ETF(BATS:CTRU) will officially be shutting down just eight months after its launch. However, the termination of the fund is not related to performance or a lack of popularity. Rather, the index that CTRU tracks, The Transparency Index, will cease to calculate performance at the end of the month. Ark Investstated that it had failed to find an alternative index to track. CTRU will close on July 26, or “as soon as practical thereafter.” This will be Ark’s first ever fund-closure.With that in mind, let’s take a look at five stocks that Cathie Wood bought this week.5 Top Stocks Cathie Wood Bought This Week1.Kratos Defense &amp; Security Solutions(KTOS)Kratos(NASDAQ:KTOS) operates as a national security company that develops weapons and communication and cybersecurity services for the U.S. and its allies. Unlike many other companies who are cutting their workforce, Kratos recently announced additional job openings at its facility in Birmingham, Alabama. The company also announced that it will invest $8.6 million at its Birmingham facility over the next five years. This investment will support advancements in hypersonic technology.From July 18 to July 20, Wood purchased219,011 shares of KTOS through two of her ETFs. After the purchases, Ark Invest now owns a total of 9.96 million shares.2.Teradyne(TER)Teradyne(NASDAQ:TER) is an automatic test equipment designer that serves customers such as Intel(NASDAQ:INTC) and Qualcomm(NASDAQ:QCOM). The company helps customers automate two key aspects of manufacturing: task automation and electronic testing. The company’s task automation process utilizes collaborative robots to help automate tasks and deliver a fast return on investment (ROI). The electronics testing process helps companies reduce the time-to-market for products using automated test equipment (ATE).From July 18 to July 20, Wood purchased53,822 shares of TER through two of her ETFs. Ark Invest now owns a total of 497,048 shares.3. Ginkgo Bioworks(DNA)Ginkgo Bioworks(NYSE:DNA) is one of the few companies that Wood has been relentlessly buying through ARKK and the ARK Genomic Revolution ETF(BATS:ARKG). On July 18, the two ETFs scooped up a total of1.15 million shares. After the purchases, Ark Invest owns a total of 86.41 million shares, making it a top ten shareholder. Across all Ark ETFs, DNA is currently the 19th largest position with a 1.63% allocation.Ginkgo is a biotech company that specializes in genetic engineering. The company is involved with programming cells in a multitude of industries, ranging from food to therapeutics. This week, Ginkgo announced acollaborationwithSumitomoChemicals, a leading chemical company in Japan. Sumitomo will leverage Ginkgo’s engineering expertise and codebase to help improve products in several industries, such as the beauty and personal care industry.4.Trimble(TRMB)Trimble(NASDAQ:TRMB) provides software and hardware solutions across a variety of industries. The company employs workers in over 40 countries, while its solutions are used in over 150 countries. Additionally, TRMB carries an average price target of $88.29among seven firms with coverage of the stock. This implies upside of more than 35% from current price levels.From July 18 to July 20, Ark Invest purchased 70,734 shares of TRMB through two of its ETFs. This marks a major shift in trend, as Ark only sold shares of Trimble between Dec. 27 and May 2. After the purchases, Ark owns a total of 2.22 million shares.5. Twist Bioscience(TWST)Twist Bioscience(NASDAQ:TWST) is a DNA synthesis company that offers DNA products to customers in several industries. The company developed a proprietary synthetic DNA manufacturing process that allows it to “minimize” the chemistry used for DNA synthesis. The miniaturization allows Twist to “reduce the reaction volumes by a factor of 1,000,000 while increasing throughput by a factor of 1,000.” As a result, Twist’s DNA process translates into time and cost savings for its customers.On July 18, ARKK and ARKG purchased a total of 39,624 shares of TWST. After the purchases, Ark now owns a total of 6.59 million shares, making it the second largest shareholder behind FMR.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Top Stocks Cathie Wood Bought This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Top Stocks Cathie Wood Bought This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-07-22 09:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nCathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ...\n\n<a href=\"https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TWST":"Twist Bioscience Corp","TER":"泰瑞达","KTOS":"克瑞拓斯安全防卫","TRMB":"天宝导航","DNA":"Ginkgo Bioworks Holdings Inc."},"source_url":"https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167504690","content_text":"Cathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ARK Innovation ETF(ARKK), are down over 45% year-to-date.Shares of Cathie Wood’s flagship exchange-traded fund (ETF), the ARK Innovation ETF(NYSEARCA:ARKK), are up about 20% the past month. Despite the short term recovery, the ETF is still down more than 45% year-to-date. Cathie Wood stocks haven’t exactly beaten the market so far this year.In related news, the ARK Transparency ETF(BATS:CTRU) will officially be shutting down just eight months after its launch. However, the termination of the fund is not related to performance or a lack of popularity. Rather, the index that CTRU tracks, The Transparency Index, will cease to calculate performance at the end of the month. Ark Investstated that it had failed to find an alternative index to track. CTRU will close on July 26, or “as soon as practical thereafter.” This will be Ark’s first ever fund-closure.With that in mind, let’s take a look at five stocks that Cathie Wood bought this week.5 Top Stocks Cathie Wood Bought This Week1.Kratos Defense & Security Solutions(KTOS)Kratos(NASDAQ:KTOS) operates as a national security company that develops weapons and communication and cybersecurity services for the U.S. and its allies. Unlike many other companies who are cutting their workforce, Kratos recently announced additional job openings at its facility in Birmingham, Alabama. The company also announced that it will invest $8.6 million at its Birmingham facility over the next five years. This investment will support advancements in hypersonic technology.From July 18 to July 20, Wood purchased219,011 shares of KTOS through two of her ETFs. After the purchases, Ark Invest now owns a total of 9.96 million shares.2.Teradyne(TER)Teradyne(NASDAQ:TER) is an automatic test equipment designer that serves customers such as Intel(NASDAQ:INTC) and Qualcomm(NASDAQ:QCOM). The company helps customers automate two key aspects of manufacturing: task automation and electronic testing. The company’s task automation process utilizes collaborative robots to help automate tasks and deliver a fast return on investment (ROI). The electronics testing process helps companies reduce the time-to-market for products using automated test equipment (ATE).From July 18 to July 20, Wood purchased53,822 shares of TER through two of her ETFs. Ark Invest now owns a total of 497,048 shares.3. Ginkgo Bioworks(DNA)Ginkgo Bioworks(NYSE:DNA) is one of the few companies that Wood has been relentlessly buying through ARKK and the ARK Genomic Revolution ETF(BATS:ARKG). On July 18, the two ETFs scooped up a total of1.15 million shares. After the purchases, Ark Invest owns a total of 86.41 million shares, making it a top ten shareholder. Across all Ark ETFs, DNA is currently the 19th largest position with a 1.63% allocation.Ginkgo is a biotech company that specializes in genetic engineering. The company is involved with programming cells in a multitude of industries, ranging from food to therapeutics. This week, Ginkgo announced acollaborationwithSumitomoChemicals, a leading chemical company in Japan. Sumitomo will leverage Ginkgo’s engineering expertise and codebase to help improve products in several industries, such as the beauty and personal care industry.4.Trimble(TRMB)Trimble(NASDAQ:TRMB) provides software and hardware solutions across a variety of industries. The company employs workers in over 40 countries, while its solutions are used in over 150 countries. Additionally, TRMB carries an average price target of $88.29among seven firms with coverage of the stock. This implies upside of more than 35% from current price levels.From July 18 to July 20, Ark Invest purchased 70,734 shares of TRMB through two of its ETFs. This marks a major shift in trend, as Ark only sold shares of Trimble between Dec. 27 and May 2. After the purchases, Ark owns a total of 2.22 million shares.5. Twist Bioscience(TWST)Twist Bioscience(NASDAQ:TWST) is a DNA synthesis company that offers DNA products to customers in several industries. The company developed a proprietary synthetic DNA manufacturing process that allows it to “minimize” the chemistry used for DNA synthesis. The miniaturization allows Twist to “reduce the reaction volumes by a factor of 1,000,000 while increasing throughput by a factor of 1,000.” As a result, Twist’s DNA process translates into time and cost savings for its customers.On July 18, ARKK and ARKG purchased a total of 39,624 shares of TWST. After the purchases, Ark now owns a total of 6.59 million shares, making it the second largest shareholder behind FMR.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9077346354,"gmtCreate":1658459152578,"gmtModify":1676536162970,"author":{"id":"3579998898288031","authorId":"3579998898288031","name":"MamaLee","avatar":"https://static.tigerbbs.com/3b65143242ad70cd231ddce7436fdb25","vip":1,"hat":"https://static.tigerbbs.com/a3dee1aa3a3a3c1814833a4d3f8a5669","crmLevel":5,"crmLevelSwitch":1,"authorIdStr":"3579998898288031","idStr":"3579998898288031"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9077346354","repostId":1167504690,"repostType":4,"repost":{"id":"1167504690","pubTimestamp":1658454795,"share":"https://ttm.financial/m/news/1167504690?lang=&edition=fundamental","pubTime":"2022-07-22 09:53","market":"us","language":"en","title":"5 Top Stocks Cathie Wood Bought This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1167504690","media":"InvestorPlace","summary":"Cathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchase","content":"<html><head></head><body><ul><li>Cathie Wood&#39;s stock purchases have largely outnumbered her sales this week.</li><li>The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).</li><li>Shares of her flagship ETF, the ARK Innovation ETF(ARKK), are down over 45% year-to-date.</li></ul>Shares of Cathie Wood’s flagship exchange-traded fund (ETF), the ARK Innovation ETF(NYSEARCA:ARKK), are up about 20% the past month. Despite the short term recovery, the ETF is still down more than 45% year-to-date. Cathie Wood stocks haven’t exactly beaten the market so far this year.In related news, the ARK Transparency ETF(BATS:CTRU) will officially be shutting down just eight months after its launch. However, the termination of the fund is not related to performance or a lack of popularity. Rather, the index that CTRU tracks, The Transparency Index, will cease to calculate performance at the end of the month. Ark Investstated that it had failed to find an alternative index to track. CTRU will close on July 26, or “as soon as practical thereafter.” This will be Ark’s first ever fund-closure.With that in mind, let’s take a look at five stocks that Cathie Wood bought this week.5 Top Stocks Cathie Wood Bought This Week1.Kratos Defense &amp; Security Solutions(KTOS)Kratos(NASDAQ:KTOS) operates as a national security company that develops weapons and communication and cybersecurity services for the U.S. and its allies. Unlike many other companies who are cutting their workforce, Kratos recently announced additional job openings at its facility in Birmingham, Alabama. The company also announced that it will invest $8.6 million at its Birmingham facility over the next five years. This investment will support advancements in hypersonic technology.From July 18 to July 20, Wood purchased219,011 shares of KTOS through two of her ETFs. After the purchases, Ark Invest now owns a total of 9.96 million shares.2.Teradyne(TER)Teradyne(NASDAQ:TER) is an automatic test equipment designer that serves customers such as Intel(NASDAQ:INTC) and Qualcomm(NASDAQ:QCOM). The company helps customers automate two key aspects of manufacturing: task automation and electronic testing. The company’s task automation process utilizes collaborative robots to help automate tasks and deliver a fast return on investment (ROI). The electronics testing process helps companies reduce the time-to-market for products using automated test equipment (ATE).From July 18 to July 20, Wood purchased53,822 shares of TER through two of her ETFs. Ark Invest now owns a total of 497,048 shares.3. Ginkgo Bioworks(DNA)Ginkgo Bioworks(NYSE:DNA) is one of the few companies that Wood has been relentlessly buying through ARKK and the ARK Genomic Revolution ETF(BATS:ARKG). On July 18, the two ETFs scooped up a total of1.15 million shares. After the purchases, Ark Invest owns a total of 86.41 million shares, making it a top ten shareholder. Across all Ark ETFs, DNA is currently the 19th largest position with a 1.63% allocation.Ginkgo is a biotech company that specializes in genetic engineering. The company is involved with programming cells in a multitude of industries, ranging from food to therapeutics. This week, Ginkgo announced acollaborationwithSumitomoChemicals, a leading chemical company in Japan. Sumitomo will leverage Ginkgo’s engineering expertise and codebase to help improve products in several industries, such as the beauty and personal care industry.4.Trimble(TRMB)Trimble(NASDAQ:TRMB) provides software and hardware solutions across a variety of industries. The company employs workers in over 40 countries, while its solutions are used in over 150 countries. Additionally, TRMB carries an average price target of $88.29among seven firms with coverage of the stock. This implies upside of more than 35% from current price levels.From July 18 to July 20, Ark Invest purchased 70,734 shares of TRMB through two of its ETFs. This marks a major shift in trend, as Ark only sold shares of Trimble between Dec. 27 and May 2. After the purchases, Ark owns a total of 2.22 million shares.5. Twist Bioscience(TWST)Twist Bioscience(NASDAQ:TWST) is a DNA synthesis company that offers DNA products to customers in several industries. The company developed a proprietary synthetic DNA manufacturing process that allows it to “minimize” the chemistry used for DNA synthesis. The miniaturization allows Twist to “reduce the reaction volumes by a factor of 1,000,000 while increasing throughput by a factor of 1,000.” As a result, Twist’s DNA process translates into time and cost savings for its customers.On July 18, ARKK and ARKG purchased a total of 39,624 shares of TWST. After the purchases, Ark now owns a total of 6.59 million shares, making it the second largest shareholder behind FMR.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Top Stocks Cathie Wood Bought This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Top Stocks Cathie Wood Bought This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-07-22 09:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nCathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ...\n\n<a href=\"https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TWST":"Twist Bioscience Corp","TER":"泰瑞达","KTOS":"克瑞拓斯安全防卫","TRMB":"天宝导航","DNA":"Ginkgo Bioworks Holdings Inc."},"source_url":"https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167504690","content_text":"Cathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ARK Innovation ETF(ARKK), are down over 45% year-to-date.Shares of Cathie Wood’s flagship exchange-traded fund (ETF), the ARK Innovation ETF(NYSEARCA:ARKK), are up about 20% the past month. Despite the short term recovery, the ETF is still down more than 45% year-to-date. Cathie Wood stocks haven’t exactly beaten the market so far this year.In related news, the ARK Transparency ETF(BATS:CTRU) will officially be shutting down just eight months after its launch. However, the termination of the fund is not related to performance or a lack of popularity. Rather, the index that CTRU tracks, The Transparency Index, will cease to calculate performance at the end of the month. Ark Investstated that it had failed to find an alternative index to track. CTRU will close on July 26, or “as soon as practical thereafter.” This will be Ark’s first ever fund-closure.With that in mind, let’s take a look at five stocks that Cathie Wood bought this week.5 Top Stocks Cathie Wood Bought This Week1.Kratos Defense & Security Solutions(KTOS)Kratos(NASDAQ:KTOS) operates as a national security company that develops weapons and communication and cybersecurity services for the U.S. and its allies. Unlike many other companies who are cutting their workforce, Kratos recently announced additional job openings at its facility in Birmingham, Alabama. The company also announced that it will invest $8.6 million at its Birmingham facility over the next five years. This investment will support advancements in hypersonic technology.From July 18 to July 20, Wood purchased219,011 shares of KTOS through two of her ETFs. After the purchases, Ark Invest now owns a total of 9.96 million shares.2.Teradyne(TER)Teradyne(NASDAQ:TER) is an automatic test equipment designer that serves customers such as Intel(NASDAQ:INTC) and Qualcomm(NASDAQ:QCOM). The company helps customers automate two key aspects of manufacturing: task automation and electronic testing. The company’s task automation process utilizes collaborative robots to help automate tasks and deliver a fast return on investment (ROI). The electronics testing process helps companies reduce the time-to-market for products using automated test equipment (ATE).From July 18 to July 20, Wood purchased53,822 shares of TER through two of her ETFs. Ark Invest now owns a total of 497,048 shares.3. Ginkgo Bioworks(DNA)Ginkgo Bioworks(NYSE:DNA) is one of the few companies that Wood has been relentlessly buying through ARKK and the ARK Genomic Revolution ETF(BATS:ARKG). On July 18, the two ETFs scooped up a total of1.15 million shares. After the purchases, Ark Invest owns a total of 86.41 million shares, making it a top ten shareholder. Across all Ark ETFs, DNA is currently the 19th largest position with a 1.63% allocation.Ginkgo is a biotech company that specializes in genetic engineering. The company is involved with programming cells in a multitude of industries, ranging from food to therapeutics. This week, Ginkgo announced acollaborationwithSumitomoChemicals, a leading chemical company in Japan. Sumitomo will leverage Ginkgo’s engineering expertise and codebase to help improve products in several industries, such as the beauty and personal care industry.4.Trimble(TRMB)Trimble(NASDAQ:TRMB) provides software and hardware solutions across a variety of industries. The company employs workers in over 40 countries, while its solutions are used in over 150 countries. Additionally, TRMB carries an average price target of $88.29among seven firms with coverage of the stock. This implies upside of more than 35% from current price levels.From July 18 to July 20, Ark Invest purchased 70,734 shares of TRMB through two of its ETFs. This marks a major shift in trend, as Ark only sold shares of Trimble between Dec. 27 and May 2. After the purchases, Ark owns a total of 2.22 million shares.5. Twist Bioscience(TWST)Twist Bioscience(NASDAQ:TWST) is a DNA synthesis company that offers DNA products to customers in several industries. The company developed a proprietary synthetic DNA manufacturing process that allows it to “minimize” the chemistry used for DNA synthesis. The miniaturization allows Twist to “reduce the reaction volumes by a factor of 1,000,000 while increasing throughput by a factor of 1,000.” As a result, Twist’s DNA process translates into time and cost savings for its customers.On July 18, ARKK and ARKG purchased a total of 39,624 shares of TWST. After the purchases, Ark now owns a total of 6.59 million shares, making it the second largest shareholder behind FMR.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9077349804,"gmtCreate":1658458589808,"gmtModify":1676536162780,"author":{"id":"3560462004935767","authorId":"3560462004935767","name":"Patjaslyn","avatar":"https://static.tigerbbs.com/d24c3405176265c91b8a1c92e36ca1e3","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3560462004935767","idStr":"3560462004935767"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9077349804","repostId":1167504690,"repostType":4,"repost":{"id":"1167504690","pubTimestamp":1658454795,"share":"https://ttm.financial/m/news/1167504690?lang=&edition=fundamental","pubTime":"2022-07-22 09:53","market":"us","language":"en","title":"5 Top Stocks Cathie Wood Bought This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1167504690","media":"InvestorPlace","summary":"Cathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchase","content":"<html><head></head><body><ul><li>Cathie Wood&#39;s stock purchases have largely outnumbered her sales this week.</li><li>The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).</li><li>Shares of her flagship ETF, the ARK Innovation ETF(ARKK), are down over 45% year-to-date.</li></ul>Shares of Cathie Wood’s flagship exchange-traded fund (ETF), the ARK Innovation ETF(NYSEARCA:ARKK), are up about 20% the past month. Despite the short term recovery, the ETF is still down more than 45% year-to-date. Cathie Wood stocks haven’t exactly beaten the market so far this year.In related news, the ARK Transparency ETF(BATS:CTRU) will officially be shutting down just eight months after its launch. However, the termination of the fund is not related to performance or a lack of popularity. Rather, the index that CTRU tracks, The Transparency Index, will cease to calculate performance at the end of the month. Ark Investstated that it had failed to find an alternative index to track. CTRU will close on July 26, or “as soon as practical thereafter.” This will be Ark’s first ever fund-closure.With that in mind, let’s take a look at five stocks that Cathie Wood bought this week.5 Top Stocks Cathie Wood Bought This Week1.Kratos Defense &amp; Security Solutions(KTOS)Kratos(NASDAQ:KTOS) operates as a national security company that develops weapons and communication and cybersecurity services for the U.S. and its allies. Unlike many other companies who are cutting their workforce, Kratos recently announced additional job openings at its facility in Birmingham, Alabama. The company also announced that it will invest $8.6 million at its Birmingham facility over the next five years. This investment will support advancements in hypersonic technology.From July 18 to July 20, Wood purchased219,011 shares of KTOS through two of her ETFs. After the purchases, Ark Invest now owns a total of 9.96 million shares.2.Teradyne(TER)Teradyne(NASDAQ:TER) is an automatic test equipment designer that serves customers such as Intel(NASDAQ:INTC) and Qualcomm(NASDAQ:QCOM). The company helps customers automate two key aspects of manufacturing: task automation and electronic testing. The company’s task automation process utilizes collaborative robots to help automate tasks and deliver a fast return on investment (ROI). The electronics testing process helps companies reduce the time-to-market for products using automated test equipment (ATE).From July 18 to July 20, Wood purchased53,822 shares of TER through two of her ETFs. Ark Invest now owns a total of 497,048 shares.3. Ginkgo Bioworks(DNA)Ginkgo Bioworks(NYSE:DNA) is one of the few companies that Wood has been relentlessly buying through ARKK and the ARK Genomic Revolution ETF(BATS:ARKG). On July 18, the two ETFs scooped up a total of1.15 million shares. After the purchases, Ark Invest owns a total of 86.41 million shares, making it a top ten shareholder. Across all Ark ETFs, DNA is currently the 19th largest position with a 1.63% allocation.Ginkgo is a biotech company that specializes in genetic engineering. The company is involved with programming cells in a multitude of industries, ranging from food to therapeutics. This week, Ginkgo announced acollaborationwithSumitomoChemicals, a leading chemical company in Japan. Sumitomo will leverage Ginkgo’s engineering expertise and codebase to help improve products in several industries, such as the beauty and personal care industry.4.Trimble(TRMB)Trimble(NASDAQ:TRMB) provides software and hardware solutions across a variety of industries. The company employs workers in over 40 countries, while its solutions are used in over 150 countries. Additionally, TRMB carries an average price target of $88.29among seven firms with coverage of the stock. This implies upside of more than 35% from current price levels.From July 18 to July 20, Ark Invest purchased 70,734 shares of TRMB through two of its ETFs. This marks a major shift in trend, as Ark only sold shares of Trimble between Dec. 27 and May 2. After the purchases, Ark owns a total of 2.22 million shares.5. Twist Bioscience(TWST)Twist Bioscience(NASDAQ:TWST) is a DNA synthesis company that offers DNA products to customers in several industries. The company developed a proprietary synthetic DNA manufacturing process that allows it to “minimize” the chemistry used for DNA synthesis. The miniaturization allows Twist to “reduce the reaction volumes by a factor of 1,000,000 while increasing throughput by a factor of 1,000.” As a result, Twist’s DNA process translates into time and cost savings for its customers.On July 18, ARKK and ARKG purchased a total of 39,624 shares of TWST. After the purchases, Ark now owns a total of 6.59 million shares, making it the second largest shareholder behind FMR.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Top Stocks Cathie Wood Bought This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Top Stocks Cathie Wood Bought This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-07-22 09:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nCathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ...\n\n<a href=\"https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TWST":"Twist Bioscience Corp","TER":"泰瑞达","KTOS":"克瑞拓斯安全防卫","TRMB":"天宝导航","DNA":"Ginkgo Bioworks Holdings Inc."},"source_url":"https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167504690","content_text":"Cathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ARK Innovation ETF(ARKK), are down over 45% year-to-date.Shares of Cathie Wood’s flagship exchange-traded fund (ETF), the ARK Innovation ETF(NYSEARCA:ARKK), are up about 20% the past month. Despite the short term recovery, the ETF is still down more than 45% year-to-date. Cathie Wood stocks haven’t exactly beaten the market so far this year.In related news, the ARK Transparency ETF(BATS:CTRU) will officially be shutting down just eight months after its launch. However, the termination of the fund is not related to performance or a lack of popularity. Rather, the index that CTRU tracks, The Transparency Index, will cease to calculate performance at the end of the month. Ark Investstated that it had failed to find an alternative index to track. CTRU will close on July 26, or “as soon as practical thereafter.” This will be Ark’s first ever fund-closure.With that in mind, let’s take a look at five stocks that Cathie Wood bought this week.5 Top Stocks Cathie Wood Bought This Week1.Kratos Defense & Security Solutions(KTOS)Kratos(NASDAQ:KTOS) operates as a national security company that develops weapons and communication and cybersecurity services for the U.S. and its allies. Unlike many other companies who are cutting their workforce, Kratos recently announced additional job openings at its facility in Birmingham, Alabama. The company also announced that it will invest $8.6 million at its Birmingham facility over the next five years. This investment will support advancements in hypersonic technology.From July 18 to July 20, Wood purchased219,011 shares of KTOS through two of her ETFs. After the purchases, Ark Invest now owns a total of 9.96 million shares.2.Teradyne(TER)Teradyne(NASDAQ:TER) is an automatic test equipment designer that serves customers such as Intel(NASDAQ:INTC) and Qualcomm(NASDAQ:QCOM). The company helps customers automate two key aspects of manufacturing: task automation and electronic testing. The company’s task automation process utilizes collaborative robots to help automate tasks and deliver a fast return on investment (ROI). The electronics testing process helps companies reduce the time-to-market for products using automated test equipment (ATE).From July 18 to July 20, Wood purchased53,822 shares of TER through two of her ETFs. Ark Invest now owns a total of 497,048 shares.3. Ginkgo Bioworks(DNA)Ginkgo Bioworks(NYSE:DNA) is one of the few companies that Wood has been relentlessly buying through ARKK and the ARK Genomic Revolution ETF(BATS:ARKG). On July 18, the two ETFs scooped up a total of1.15 million shares. After the purchases, Ark Invest owns a total of 86.41 million shares, making it a top ten shareholder. Across all Ark ETFs, DNA is currently the 19th largest position with a 1.63% allocation.Ginkgo is a biotech company that specializes in genetic engineering. The company is involved with programming cells in a multitude of industries, ranging from food to therapeutics. This week, Ginkgo announced acollaborationwithSumitomoChemicals, a leading chemical company in Japan. Sumitomo will leverage Ginkgo’s engineering expertise and codebase to help improve products in several industries, such as the beauty and personal care industry.4.Trimble(TRMB)Trimble(NASDAQ:TRMB) provides software and hardware solutions across a variety of industries. The company employs workers in over 40 countries, while its solutions are used in over 150 countries. Additionally, TRMB carries an average price target of $88.29among seven firms with coverage of the stock. This implies upside of more than 35% from current price levels.From July 18 to July 20, Ark Invest purchased 70,734 shares of TRMB through two of its ETFs. This marks a major shift in trend, as Ark only sold shares of Trimble between Dec. 27 and May 2. After the purchases, Ark owns a total of 2.22 million shares.5. Twist Bioscience(TWST)Twist Bioscience(NASDAQ:TWST) is a DNA synthesis company that offers DNA products to customers in several industries. The company developed a proprietary synthetic DNA manufacturing process that allows it to “minimize” the chemistry used for DNA synthesis. The miniaturization allows Twist to “reduce the reaction volumes by a factor of 1,000,000 while increasing throughput by a factor of 1,000.” As a result, Twist’s DNA process translates into time and cost savings for its customers.On July 18, ARKK and ARKG purchased a total of 39,624 shares of TWST. After the purchases, Ark now owns a total of 6.59 million shares, making it the second largest shareholder behind FMR.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9077357488,"gmtCreate":1658458109344,"gmtModify":1676536162741,"author":{"id":"3581589039331867","authorId":"3581589039331867","name":"jjt87","avatar":"https://static.tigerbbs.com/42cf95c9822b5198293ea31c46dfbe92","vip":1,"crmLevel":8,"crmLevelSwitch":0,"authorIdStr":"3581589039331867","idStr":"3581589039331867"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9077357488","repostId":1167504690,"repostType":4,"repost":{"id":"1167504690","pubTimestamp":1658454795,"share":"https://ttm.financial/m/news/1167504690?lang=&edition=fundamental","pubTime":"2022-07-22 09:53","market":"us","language":"en","title":"5 Top Stocks Cathie Wood Bought This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1167504690","media":"InvestorPlace","summary":"Cathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchase","content":"<html><head></head><body><ul><li>Cathie Wood&#39;s stock purchases have largely outnumbered her sales this week.</li><li>The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).</li><li>Shares of her flagship ETF, the ARK Innovation ETF(ARKK), are down over 45% year-to-date.</li></ul>Shares of Cathie Wood’s flagship exchange-traded fund (ETF), the ARK Innovation ETF(NYSEARCA:ARKK), are up about 20% the past month. Despite the short term recovery, the ETF is still down more than 45% year-to-date. Cathie Wood stocks haven’t exactly beaten the market so far this year.In related news, the ARK Transparency ETF(BATS:CTRU) will officially be shutting down just eight months after its launch. However, the termination of the fund is not related to performance or a lack of popularity. Rather, the index that CTRU tracks, The Transparency Index, will cease to calculate performance at the end of the month. Ark Investstated that it had failed to find an alternative index to track. CTRU will close on July 26, or “as soon as practical thereafter.” This will be Ark’s first ever fund-closure.With that in mind, let’s take a look at five stocks that Cathie Wood bought this week.5 Top Stocks Cathie Wood Bought This Week1.Kratos Defense &amp; Security Solutions(KTOS)Kratos(NASDAQ:KTOS) operates as a national security company that develops weapons and communication and cybersecurity services for the U.S. and its allies. Unlike many other companies who are cutting their workforce, Kratos recently announced additional job openings at its facility in Birmingham, Alabama. The company also announced that it will invest $8.6 million at its Birmingham facility over the next five years. This investment will support advancements in hypersonic technology.From July 18 to July 20, Wood purchased219,011 shares of KTOS through two of her ETFs. After the purchases, Ark Invest now owns a total of 9.96 million shares.2.Teradyne(TER)Teradyne(NASDAQ:TER) is an automatic test equipment designer that serves customers such as Intel(NASDAQ:INTC) and Qualcomm(NASDAQ:QCOM). The company helps customers automate two key aspects of manufacturing: task automation and electronic testing. The company’s task automation process utilizes collaborative robots to help automate tasks and deliver a fast return on investment (ROI). The electronics testing process helps companies reduce the time-to-market for products using automated test equipment (ATE).From July 18 to July 20, Wood purchased53,822 shares of TER through two of her ETFs. Ark Invest now owns a total of 497,048 shares.3. Ginkgo Bioworks(DNA)Ginkgo Bioworks(NYSE:DNA) is one of the few companies that Wood has been relentlessly buying through ARKK and the ARK Genomic Revolution ETF(BATS:ARKG). On July 18, the two ETFs scooped up a total of1.15 million shares. After the purchases, Ark Invest owns a total of 86.41 million shares, making it a top ten shareholder. Across all Ark ETFs, DNA is currently the 19th largest position with a 1.63% allocation.Ginkgo is a biotech company that specializes in genetic engineering. The company is involved with programming cells in a multitude of industries, ranging from food to therapeutics. This week, Ginkgo announced acollaborationwithSumitomoChemicals, a leading chemical company in Japan. Sumitomo will leverage Ginkgo’s engineering expertise and codebase to help improve products in several industries, such as the beauty and personal care industry.4.Trimble(TRMB)Trimble(NASDAQ:TRMB) provides software and hardware solutions across a variety of industries. The company employs workers in over 40 countries, while its solutions are used in over 150 countries. Additionally, TRMB carries an average price target of $88.29among seven firms with coverage of the stock. This implies upside of more than 35% from current price levels.From July 18 to July 20, Ark Invest purchased 70,734 shares of TRMB through two of its ETFs. This marks a major shift in trend, as Ark only sold shares of Trimble between Dec. 27 and May 2. After the purchases, Ark owns a total of 2.22 million shares.5. Twist Bioscience(TWST)Twist Bioscience(NASDAQ:TWST) is a DNA synthesis company that offers DNA products to customers in several industries. The company developed a proprietary synthetic DNA manufacturing process that allows it to “minimize” the chemistry used for DNA synthesis. The miniaturization allows Twist to “reduce the reaction volumes by a factor of 1,000,000 while increasing throughput by a factor of 1,000.” As a result, Twist’s DNA process translates into time and cost savings for its customers.On July 18, ARKK and ARKG purchased a total of 39,624 shares of TWST. After the purchases, Ark now owns a total of 6.59 million shares, making it the second largest shareholder behind FMR.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Top Stocks Cathie Wood Bought This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Top Stocks Cathie Wood Bought This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-07-22 09:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nCathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ...\n\n<a href=\"https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TWST":"Twist Bioscience Corp","TER":"泰瑞达","KTOS":"克瑞拓斯安全防卫","TRMB":"天宝导航","DNA":"Ginkgo Bioworks Holdings Inc."},"source_url":"https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167504690","content_text":"Cathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ARK Innovation ETF(ARKK), are down over 45% year-to-date.Shares of Cathie Wood’s flagship exchange-traded fund (ETF), the ARK Innovation ETF(NYSEARCA:ARKK), are up about 20% the past month. Despite the short term recovery, the ETF is still down more than 45% year-to-date. Cathie Wood stocks haven’t exactly beaten the market so far this year.In related news, the ARK Transparency ETF(BATS:CTRU) will officially be shutting down just eight months after its launch. However, the termination of the fund is not related to performance or a lack of popularity. Rather, the index that CTRU tracks, The Transparency Index, will cease to calculate performance at the end of the month. Ark Investstated that it had failed to find an alternative index to track. CTRU will close on July 26, or “as soon as practical thereafter.” This will be Ark’s first ever fund-closure.With that in mind, let’s take a look at five stocks that Cathie Wood bought this week.5 Top Stocks Cathie Wood Bought This Week1.Kratos Defense & Security Solutions(KTOS)Kratos(NASDAQ:KTOS) operates as a national security company that develops weapons and communication and cybersecurity services for the U.S. and its allies. Unlike many other companies who are cutting their workforce, Kratos recently announced additional job openings at its facility in Birmingham, Alabama. The company also announced that it will invest $8.6 million at its Birmingham facility over the next five years. This investment will support advancements in hypersonic technology.From July 18 to July 20, Wood purchased219,011 shares of KTOS through two of her ETFs. After the purchases, Ark Invest now owns a total of 9.96 million shares.2.Teradyne(TER)Teradyne(NASDAQ:TER) is an automatic test equipment designer that serves customers such as Intel(NASDAQ:INTC) and Qualcomm(NASDAQ:QCOM). The company helps customers automate two key aspects of manufacturing: task automation and electronic testing. The company’s task automation process utilizes collaborative robots to help automate tasks and deliver a fast return on investment (ROI). The electronics testing process helps companies reduce the time-to-market for products using automated test equipment (ATE).From July 18 to July 20, Wood purchased53,822 shares of TER through two of her ETFs. Ark Invest now owns a total of 497,048 shares.3. Ginkgo Bioworks(DNA)Ginkgo Bioworks(NYSE:DNA) is one of the few companies that Wood has been relentlessly buying through ARKK and the ARK Genomic Revolution ETF(BATS:ARKG). On July 18, the two ETFs scooped up a total of1.15 million shares. After the purchases, Ark Invest owns a total of 86.41 million shares, making it a top ten shareholder. Across all Ark ETFs, DNA is currently the 19th largest position with a 1.63% allocation.Ginkgo is a biotech company that specializes in genetic engineering. The company is involved with programming cells in a multitude of industries, ranging from food to therapeutics. This week, Ginkgo announced acollaborationwithSumitomoChemicals, a leading chemical company in Japan. Sumitomo will leverage Ginkgo’s engineering expertise and codebase to help improve products in several industries, such as the beauty and personal care industry.4.Trimble(TRMB)Trimble(NASDAQ:TRMB) provides software and hardware solutions across a variety of industries. The company employs workers in over 40 countries, while its solutions are used in over 150 countries. Additionally, TRMB carries an average price target of $88.29among seven firms with coverage of the stock. This implies upside of more than 35% from current price levels.From July 18 to July 20, Ark Invest purchased 70,734 shares of TRMB through two of its ETFs. This marks a major shift in trend, as Ark only sold shares of Trimble between Dec. 27 and May 2. After the purchases, Ark owns a total of 2.22 million shares.5. Twist Bioscience(TWST)Twist Bioscience(NASDAQ:TWST) is a DNA synthesis company that offers DNA products to customers in several industries. The company developed a proprietary synthetic DNA manufacturing process that allows it to “minimize” the chemistry used for DNA synthesis. The miniaturization allows Twist to “reduce the reaction volumes by a factor of 1,000,000 while increasing throughput by a factor of 1,000.” As a result, Twist’s DNA process translates into time and cost savings for its customers.On July 18, ARKK and ARKG purchased a total of 39,624 shares of TWST. After the purchases, Ark now owns a total of 6.59 million shares, making it the second largest shareholder behind FMR.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9077352348,"gmtCreate":1658457694684,"gmtModify":1676536162671,"author":{"id":"3584865393434866","authorId":"3584865393434866","name":"Hi001","avatar":"https://static.tigerbbs.com/fdb94b71a386dca6e0927a9a6df8e9d6","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3584865393434866","idStr":"3584865393434866"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":11,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9077352348","repostId":1167504690,"repostType":4,"repost":{"id":"1167504690","pubTimestamp":1658454795,"share":"https://ttm.financial/m/news/1167504690?lang=&edition=fundamental","pubTime":"2022-07-22 09:53","market":"us","language":"en","title":"5 Top Stocks Cathie Wood Bought This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1167504690","media":"InvestorPlace","summary":"Cathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchase","content":"<html><head></head><body><ul><li>Cathie Wood&#39;s stock purchases have largely outnumbered her sales this week.</li><li>The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).</li><li>Shares of her flagship ETF, the ARK Innovation ETF(ARKK), are down over 45% year-to-date.</li></ul>Shares of Cathie Wood’s flagship exchange-traded fund (ETF), the ARK Innovation ETF(NYSEARCA:ARKK), are up about 20% the past month. Despite the short term recovery, the ETF is still down more than 45% year-to-date. Cathie Wood stocks haven’t exactly beaten the market so far this year.In related news, the ARK Transparency ETF(BATS:CTRU) will officially be shutting down just eight months after its launch. However, the termination of the fund is not related to performance or a lack of popularity. Rather, the index that CTRU tracks, The Transparency Index, will cease to calculate performance at the end of the month. Ark Investstated that it had failed to find an alternative index to track. CTRU will close on July 26, or “as soon as practical thereafter.” This will be Ark’s first ever fund-closure.With that in mind, let’s take a look at five stocks that Cathie Wood bought this week.5 Top Stocks Cathie Wood Bought This Week1.Kratos Defense &amp; Security Solutions(KTOS)Kratos(NASDAQ:KTOS) operates as a national security company that develops weapons and communication and cybersecurity services for the U.S. and its allies. Unlike many other companies who are cutting their workforce, Kratos recently announced additional job openings at its facility in Birmingham, Alabama. The company also announced that it will invest $8.6 million at its Birmingham facility over the next five years. This investment will support advancements in hypersonic technology.From July 18 to July 20, Wood purchased219,011 shares of KTOS through two of her ETFs. After the purchases, Ark Invest now owns a total of 9.96 million shares.2.Teradyne(TER)Teradyne(NASDAQ:TER) is an automatic test equipment designer that serves customers such as Intel(NASDAQ:INTC) and Qualcomm(NASDAQ:QCOM). The company helps customers automate two key aspects of manufacturing: task automation and electronic testing. The company’s task automation process utilizes collaborative robots to help automate tasks and deliver a fast return on investment (ROI). The electronics testing process helps companies reduce the time-to-market for products using automated test equipment (ATE).From July 18 to July 20, Wood purchased53,822 shares of TER through two of her ETFs. Ark Invest now owns a total of 497,048 shares.3. Ginkgo Bioworks(DNA)Ginkgo Bioworks(NYSE:DNA) is one of the few companies that Wood has been relentlessly buying through ARKK and the ARK Genomic Revolution ETF(BATS:ARKG). On July 18, the two ETFs scooped up a total of1.15 million shares. After the purchases, Ark Invest owns a total of 86.41 million shares, making it a top ten shareholder. Across all Ark ETFs, DNA is currently the 19th largest position with a 1.63% allocation.Ginkgo is a biotech company that specializes in genetic engineering. The company is involved with programming cells in a multitude of industries, ranging from food to therapeutics. This week, Ginkgo announced acollaborationwithSumitomoChemicals, a leading chemical company in Japan. Sumitomo will leverage Ginkgo’s engineering expertise and codebase to help improve products in several industries, such as the beauty and personal care industry.4.Trimble(TRMB)Trimble(NASDAQ:TRMB) provides software and hardware solutions across a variety of industries. The company employs workers in over 40 countries, while its solutions are used in over 150 countries. Additionally, TRMB carries an average price target of $88.29among seven firms with coverage of the stock. This implies upside of more than 35% from current price levels.From July 18 to July 20, Ark Invest purchased 70,734 shares of TRMB through two of its ETFs. This marks a major shift in trend, as Ark only sold shares of Trimble between Dec. 27 and May 2. After the purchases, Ark owns a total of 2.22 million shares.5. Twist Bioscience(TWST)Twist Bioscience(NASDAQ:TWST) is a DNA synthesis company that offers DNA products to customers in several industries. The company developed a proprietary synthetic DNA manufacturing process that allows it to “minimize” the chemistry used for DNA synthesis. The miniaturization allows Twist to “reduce the reaction volumes by a factor of 1,000,000 while increasing throughput by a factor of 1,000.” As a result, Twist’s DNA process translates into time and cost savings for its customers.On July 18, ARKK and ARKG purchased a total of 39,624 shares of TWST. After the purchases, Ark now owns a total of 6.59 million shares, making it the second largest shareholder behind FMR.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Top Stocks Cathie Wood Bought This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Top Stocks Cathie Wood Bought This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-07-22 09:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nCathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ...\n\n<a href=\"https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TWST":"Twist Bioscience Corp","TER":"泰瑞达","KTOS":"克瑞拓斯安全防卫","TRMB":"天宝导航","DNA":"Ginkgo Bioworks Holdings Inc."},"source_url":"https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167504690","content_text":"Cathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ARK Innovation ETF(ARKK), are down over 45% year-to-date.Shares of Cathie Wood’s flagship exchange-traded fund (ETF), the ARK Innovation ETF(NYSEARCA:ARKK), are up about 20% the past month. Despite the short term recovery, the ETF is still down more than 45% year-to-date. Cathie Wood stocks haven’t exactly beaten the market so far this year.In related news, the ARK Transparency ETF(BATS:CTRU) will officially be shutting down just eight months after its launch. However, the termination of the fund is not related to performance or a lack of popularity. Rather, the index that CTRU tracks, The Transparency Index, will cease to calculate performance at the end of the month. Ark Investstated that it had failed to find an alternative index to track. CTRU will close on July 26, or “as soon as practical thereafter.” This will be Ark’s first ever fund-closure.With that in mind, let’s take a look at five stocks that Cathie Wood bought this week.5 Top Stocks Cathie Wood Bought This Week1.Kratos Defense & Security Solutions(KTOS)Kratos(NASDAQ:KTOS) operates as a national security company that develops weapons and communication and cybersecurity services for the U.S. and its allies. Unlike many other companies who are cutting their workforce, Kratos recently announced additional job openings at its facility in Birmingham, Alabama. The company also announced that it will invest $8.6 million at its Birmingham facility over the next five years. This investment will support advancements in hypersonic technology.From July 18 to July 20, Wood purchased219,011 shares of KTOS through two of her ETFs. After the purchases, Ark Invest now owns a total of 9.96 million shares.2.Teradyne(TER)Teradyne(NASDAQ:TER) is an automatic test equipment designer that serves customers such as Intel(NASDAQ:INTC) and Qualcomm(NASDAQ:QCOM). The company helps customers automate two key aspects of manufacturing: task automation and electronic testing. The company’s task automation process utilizes collaborative robots to help automate tasks and deliver a fast return on investment (ROI). The electronics testing process helps companies reduce the time-to-market for products using automated test equipment (ATE).From July 18 to July 20, Wood purchased53,822 shares of TER through two of her ETFs. Ark Invest now owns a total of 497,048 shares.3. Ginkgo Bioworks(DNA)Ginkgo Bioworks(NYSE:DNA) is one of the few companies that Wood has been relentlessly buying through ARKK and the ARK Genomic Revolution ETF(BATS:ARKG). On July 18, the two ETFs scooped up a total of1.15 million shares. After the purchases, Ark Invest owns a total of 86.41 million shares, making it a top ten shareholder. Across all Ark ETFs, DNA is currently the 19th largest position with a 1.63% allocation.Ginkgo is a biotech company that specializes in genetic engineering. The company is involved with programming cells in a multitude of industries, ranging from food to therapeutics. This week, Ginkgo announced acollaborationwithSumitomoChemicals, a leading chemical company in Japan. Sumitomo will leverage Ginkgo’s engineering expertise and codebase to help improve products in several industries, such as the beauty and personal care industry.4.Trimble(TRMB)Trimble(NASDAQ:TRMB) provides software and hardware solutions across a variety of industries. The company employs workers in over 40 countries, while its solutions are used in over 150 countries. Additionally, TRMB carries an average price target of $88.29among seven firms with coverage of the stock. This implies upside of more than 35% from current price levels.From July 18 to July 20, Ark Invest purchased 70,734 shares of TRMB through two of its ETFs. This marks a major shift in trend, as Ark only sold shares of Trimble between Dec. 27 and May 2. After the purchases, Ark owns a total of 2.22 million shares.5. Twist Bioscience(TWST)Twist Bioscience(NASDAQ:TWST) is a DNA synthesis company that offers DNA products to customers in several industries. The company developed a proprietary synthetic DNA manufacturing process that allows it to “minimize” the chemistry used for DNA synthesis. The miniaturization allows Twist to “reduce the reaction volumes by a factor of 1,000,000 while increasing throughput by a factor of 1,000.” As a result, Twist’s DNA process translates into time and cost savings for its customers.On July 18, ARKK and ARKG purchased a total of 39,624 shares of TWST. After the purchases, Ark now owns a total of 6.59 million shares, making it the second largest shareholder behind FMR.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9077356700,"gmtCreate":1658457655401,"gmtModify":1676536162663,"author":{"id":"3555755639757611","authorId":"3555755639757611","name":"nxw","avatar":"https://static.tigerbbs.com/0a3041e78835567c8db5934504534a17","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3555755639757611","idStr":"3555755639757611"},"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9077356700","repostId":1167504690,"repostType":4,"repost":{"id":"1167504690","pubTimestamp":1658454795,"share":"https://ttm.financial/m/news/1167504690?lang=&edition=fundamental","pubTime":"2022-07-22 09:53","market":"us","language":"en","title":"5 Top Stocks Cathie Wood Bought This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1167504690","media":"InvestorPlace","summary":"Cathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchase","content":"<html><head></head><body><ul><li>Cathie Wood&#39;s stock purchases have largely outnumbered her sales this week.</li><li>The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).</li><li>Shares of her flagship ETF, the ARK Innovation ETF(ARKK), are down over 45% year-to-date.</li></ul>Shares of Cathie Wood’s flagship exchange-traded fund (ETF), the ARK Innovation ETF(NYSEARCA:ARKK), are up about 20% the past month. Despite the short term recovery, the ETF is still down more than 45% year-to-date. Cathie Wood stocks haven’t exactly beaten the market so far this year.In related news, the ARK Transparency ETF(BATS:CTRU) will officially be shutting down just eight months after its launch. However, the termination of the fund is not related to performance or a lack of popularity. Rather, the index that CTRU tracks, The Transparency Index, will cease to calculate performance at the end of the month. Ark Investstated that it had failed to find an alternative index to track. CTRU will close on July 26, or “as soon as practical thereafter.” This will be Ark’s first ever fund-closure.With that in mind, let’s take a look at five stocks that Cathie Wood bought this week.5 Top Stocks Cathie Wood Bought This Week1.Kratos Defense &amp; Security Solutions(KTOS)Kratos(NASDAQ:KTOS) operates as a national security company that develops weapons and communication and cybersecurity services for the U.S. and its allies. Unlike many other companies who are cutting their workforce, Kratos recently announced additional job openings at its facility in Birmingham, Alabama. The company also announced that it will invest $8.6 million at its Birmingham facility over the next five years. This investment will support advancements in hypersonic technology.From July 18 to July 20, Wood purchased219,011 shares of KTOS through two of her ETFs. After the purchases, Ark Invest now owns a total of 9.96 million shares.2.Teradyne(TER)Teradyne(NASDAQ:TER) is an automatic test equipment designer that serves customers such as Intel(NASDAQ:INTC) and Qualcomm(NASDAQ:QCOM). The company helps customers automate two key aspects of manufacturing: task automation and electronic testing. The company’s task automation process utilizes collaborative robots to help automate tasks and deliver a fast return on investment (ROI). The electronics testing process helps companies reduce the time-to-market for products using automated test equipment (ATE).From July 18 to July 20, Wood purchased53,822 shares of TER through two of her ETFs. Ark Invest now owns a total of 497,048 shares.3. Ginkgo Bioworks(DNA)Ginkgo Bioworks(NYSE:DNA) is one of the few companies that Wood has been relentlessly buying through ARKK and the ARK Genomic Revolution ETF(BATS:ARKG). On July 18, the two ETFs scooped up a total of1.15 million shares. After the purchases, Ark Invest owns a total of 86.41 million shares, making it a top ten shareholder. Across all Ark ETFs, DNA is currently the 19th largest position with a 1.63% allocation.Ginkgo is a biotech company that specializes in genetic engineering. The company is involved with programming cells in a multitude of industries, ranging from food to therapeutics. This week, Ginkgo announced acollaborationwithSumitomoChemicals, a leading chemical company in Japan. Sumitomo will leverage Ginkgo’s engineering expertise and codebase to help improve products in several industries, such as the beauty and personal care industry.4.Trimble(TRMB)Trimble(NASDAQ:TRMB) provides software and hardware solutions across a variety of industries. The company employs workers in over 40 countries, while its solutions are used in over 150 countries. Additionally, TRMB carries an average price target of $88.29among seven firms with coverage of the stock. This implies upside of more than 35% from current price levels.From July 18 to July 20, Ark Invest purchased 70,734 shares of TRMB through two of its ETFs. This marks a major shift in trend, as Ark only sold shares of Trimble between Dec. 27 and May 2. After the purchases, Ark owns a total of 2.22 million shares.5. Twist Bioscience(TWST)Twist Bioscience(NASDAQ:TWST) is a DNA synthesis company that offers DNA products to customers in several industries. The company developed a proprietary synthetic DNA manufacturing process that allows it to “minimize” the chemistry used for DNA synthesis. The miniaturization allows Twist to “reduce the reaction volumes by a factor of 1,000,000 while increasing throughput by a factor of 1,000.” As a result, Twist’s DNA process translates into time and cost savings for its customers.On July 18, ARKK and ARKG purchased a total of 39,624 shares of TWST. After the purchases, Ark now owns a total of 6.59 million shares, making it the second largest shareholder behind FMR.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Top Stocks Cathie Wood Bought This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Top Stocks Cathie Wood Bought This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-07-22 09:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nCathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ...\n\n<a href=\"https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TWST":"Twist Bioscience Corp","TER":"泰瑞达","KTOS":"克瑞拓斯安全防卫","TRMB":"天宝导航","DNA":"Ginkgo Bioworks Holdings Inc."},"source_url":"https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167504690","content_text":"Cathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ARK Innovation ETF(ARKK), are down over 45% year-to-date.Shares of Cathie Wood’s flagship exchange-traded fund (ETF), the ARK Innovation ETF(NYSEARCA:ARKK), are up about 20% the past month. Despite the short term recovery, the ETF is still down more than 45% year-to-date. Cathie Wood stocks haven’t exactly beaten the market so far this year.In related news, the ARK Transparency ETF(BATS:CTRU) will officially be shutting down just eight months after its launch. However, the termination of the fund is not related to performance or a lack of popularity. Rather, the index that CTRU tracks, The Transparency Index, will cease to calculate performance at the end of the month. Ark Investstated that it had failed to find an alternative index to track. CTRU will close on July 26, or “as soon as practical thereafter.” This will be Ark’s first ever fund-closure.With that in mind, let’s take a look at five stocks that Cathie Wood bought this week.5 Top Stocks Cathie Wood Bought This Week1.Kratos Defense & Security Solutions(KTOS)Kratos(NASDAQ:KTOS) operates as a national security company that develops weapons and communication and cybersecurity services for the U.S. and its allies. Unlike many other companies who are cutting their workforce, Kratos recently announced additional job openings at its facility in Birmingham, Alabama. The company also announced that it will invest $8.6 million at its Birmingham facility over the next five years. This investment will support advancements in hypersonic technology.From July 18 to July 20, Wood purchased219,011 shares of KTOS through two of her ETFs. After the purchases, Ark Invest now owns a total of 9.96 million shares.2.Teradyne(TER)Teradyne(NASDAQ:TER) is an automatic test equipment designer that serves customers such as Intel(NASDAQ:INTC) and Qualcomm(NASDAQ:QCOM). The company helps customers automate two key aspects of manufacturing: task automation and electronic testing. The company’s task automation process utilizes collaborative robots to help automate tasks and deliver a fast return on investment (ROI). The electronics testing process helps companies reduce the time-to-market for products using automated test equipment (ATE).From July 18 to July 20, Wood purchased53,822 shares of TER through two of her ETFs. Ark Invest now owns a total of 497,048 shares.3. Ginkgo Bioworks(DNA)Ginkgo Bioworks(NYSE:DNA) is one of the few companies that Wood has been relentlessly buying through ARKK and the ARK Genomic Revolution ETF(BATS:ARKG). On July 18, the two ETFs scooped up a total of1.15 million shares. After the purchases, Ark Invest owns a total of 86.41 million shares, making it a top ten shareholder. Across all Ark ETFs, DNA is currently the 19th largest position with a 1.63% allocation.Ginkgo is a biotech company that specializes in genetic engineering. The company is involved with programming cells in a multitude of industries, ranging from food to therapeutics. This week, Ginkgo announced acollaborationwithSumitomoChemicals, a leading chemical company in Japan. Sumitomo will leverage Ginkgo’s engineering expertise and codebase to help improve products in several industries, such as the beauty and personal care industry.4.Trimble(TRMB)Trimble(NASDAQ:TRMB) provides software and hardware solutions across a variety of industries. The company employs workers in over 40 countries, while its solutions are used in over 150 countries. Additionally, TRMB carries an average price target of $88.29among seven firms with coverage of the stock. This implies upside of more than 35% from current price levels.From July 18 to July 20, Ark Invest purchased 70,734 shares of TRMB through two of its ETFs. This marks a major shift in trend, as Ark only sold shares of Trimble between Dec. 27 and May 2. After the purchases, Ark owns a total of 2.22 million shares.5. Twist Bioscience(TWST)Twist Bioscience(NASDAQ:TWST) is a DNA synthesis company that offers DNA products to customers in several industries. The company developed a proprietary synthetic DNA manufacturing process that allows it to “minimize” the chemistry used for DNA synthesis. The miniaturization allows Twist to “reduce the reaction volumes by a factor of 1,000,000 while increasing throughput by a factor of 1,000.” As a result, Twist’s DNA process translates into time and cost savings for its customers.On July 18, ARKK and ARKG purchased a total of 39,624 shares of TWST. After the purchases, Ark now owns a total of 6.59 million shares, making it the second largest shareholder behind FMR.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9077356461,"gmtCreate":1658457655354,"gmtModify":1676536162663,"author":{"id":"3565663543754207","authorId":"3565663543754207","name":"och","avatar":"https://static.tigerbbs.com/1c195b2a32a90ae2210984600e352644","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3565663543754207","idStr":"3565663543754207"},"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9077356461","repostId":1167504690,"repostType":2,"repost":{"id":"1167504690","pubTimestamp":1658454795,"share":"https://ttm.financial/m/news/1167504690?lang=&edition=fundamental","pubTime":"2022-07-22 09:53","market":"us","language":"en","title":"5 Top Stocks Cathie Wood Bought This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1167504690","media":"InvestorPlace","summary":"Cathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchase","content":"<html><head></head><body><ul><li>Cathie Wood&#39;s stock purchases have largely outnumbered her sales this week.</li><li>The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).</li><li>Shares of her flagship ETF, the ARK Innovation ETF(ARKK), are down over 45% year-to-date.</li></ul>Shares of Cathie Wood’s flagship exchange-traded fund (ETF), the ARK Innovation ETF(NYSEARCA:ARKK), are up about 20% the past month. Despite the short term recovery, the ETF is still down more than 45% year-to-date. Cathie Wood stocks haven’t exactly beaten the market so far this year.In related news, the ARK Transparency ETF(BATS:CTRU) will officially be shutting down just eight months after its launch. However, the termination of the fund is not related to performance or a lack of popularity. Rather, the index that CTRU tracks, The Transparency Index, will cease to calculate performance at the end of the month. Ark Investstated that it had failed to find an alternative index to track. CTRU will close on July 26, or “as soon as practical thereafter.” This will be Ark’s first ever fund-closure.With that in mind, let’s take a look at five stocks that Cathie Wood bought this week.5 Top Stocks Cathie Wood Bought This Week1.Kratos Defense &amp; Security Solutions(KTOS)Kratos(NASDAQ:KTOS) operates as a national security company that develops weapons and communication and cybersecurity services for the U.S. and its allies. Unlike many other companies who are cutting their workforce, Kratos recently announced additional job openings at its facility in Birmingham, Alabama. The company also announced that it will invest $8.6 million at its Birmingham facility over the next five years. This investment will support advancements in hypersonic technology.From July 18 to July 20, Wood purchased219,011 shares of KTOS through two of her ETFs. After the purchases, Ark Invest now owns a total of 9.96 million shares.2.Teradyne(TER)Teradyne(NASDAQ:TER) is an automatic test equipment designer that serves customers such as Intel(NASDAQ:INTC) and Qualcomm(NASDAQ:QCOM). The company helps customers automate two key aspects of manufacturing: task automation and electronic testing. The company’s task automation process utilizes collaborative robots to help automate tasks and deliver a fast return on investment (ROI). The electronics testing process helps companies reduce the time-to-market for products using automated test equipment (ATE).From July 18 to July 20, Wood purchased53,822 shares of TER through two of her ETFs. Ark Invest now owns a total of 497,048 shares.3. Ginkgo Bioworks(DNA)Ginkgo Bioworks(NYSE:DNA) is one of the few companies that Wood has been relentlessly buying through ARKK and the ARK Genomic Revolution ETF(BATS:ARKG). On July 18, the two ETFs scooped up a total of1.15 million shares. After the purchases, Ark Invest owns a total of 86.41 million shares, making it a top ten shareholder. Across all Ark ETFs, DNA is currently the 19th largest position with a 1.63% allocation.Ginkgo is a biotech company that specializes in genetic engineering. The company is involved with programming cells in a multitude of industries, ranging from food to therapeutics. This week, Ginkgo announced acollaborationwithSumitomoChemicals, a leading chemical company in Japan. Sumitomo will leverage Ginkgo’s engineering expertise and codebase to help improve products in several industries, such as the beauty and personal care industry.4.Trimble(TRMB)Trimble(NASDAQ:TRMB) provides software and hardware solutions across a variety of industries. The company employs workers in over 40 countries, while its solutions are used in over 150 countries. Additionally, TRMB carries an average price target of $88.29among seven firms with coverage of the stock. This implies upside of more than 35% from current price levels.From July 18 to July 20, Ark Invest purchased 70,734 shares of TRMB through two of its ETFs. This marks a major shift in trend, as Ark only sold shares of Trimble between Dec. 27 and May 2. After the purchases, Ark owns a total of 2.22 million shares.5. Twist Bioscience(TWST)Twist Bioscience(NASDAQ:TWST) is a DNA synthesis company that offers DNA products to customers in several industries. The company developed a proprietary synthetic DNA manufacturing process that allows it to “minimize” the chemistry used for DNA synthesis. The miniaturization allows Twist to “reduce the reaction volumes by a factor of 1,000,000 while increasing throughput by a factor of 1,000.” As a result, Twist’s DNA process translates into time and cost savings for its customers.On July 18, ARKK and ARKG purchased a total of 39,624 shares of TWST. After the purchases, Ark now owns a total of 6.59 million shares, making it the second largest shareholder behind FMR.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Top Stocks Cathie Wood Bought This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Top Stocks Cathie Wood Bought This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-07-22 09:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nCathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ...\n\n<a href=\"https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TWST":"Twist Bioscience Corp","TER":"泰瑞达","KTOS":"克瑞拓斯安全防卫","TRMB":"天宝导航","DNA":"Ginkgo Bioworks Holdings Inc."},"source_url":"https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167504690","content_text":"Cathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ARK Innovation ETF(ARKK), are down over 45% year-to-date.Shares of Cathie Wood’s flagship exchange-traded fund (ETF), the ARK Innovation ETF(NYSEARCA:ARKK), are up about 20% the past month. Despite the short term recovery, the ETF is still down more than 45% year-to-date. Cathie Wood stocks haven’t exactly beaten the market so far this year.In related news, the ARK Transparency ETF(BATS:CTRU) will officially be shutting down just eight months after its launch. However, the termination of the fund is not related to performance or a lack of popularity. Rather, the index that CTRU tracks, The Transparency Index, will cease to calculate performance at the end of the month. Ark Investstated that it had failed to find an alternative index to track. CTRU will close on July 26, or “as soon as practical thereafter.” This will be Ark’s first ever fund-closure.With that in mind, let’s take a look at five stocks that Cathie Wood bought this week.5 Top Stocks Cathie Wood Bought This Week1.Kratos Defense & Security Solutions(KTOS)Kratos(NASDAQ:KTOS) operates as a national security company that develops weapons and communication and cybersecurity services for the U.S. and its allies. Unlike many other companies who are cutting their workforce, Kratos recently announced additional job openings at its facility in Birmingham, Alabama. The company also announced that it will invest $8.6 million at its Birmingham facility over the next five years. This investment will support advancements in hypersonic technology.From July 18 to July 20, Wood purchased219,011 shares of KTOS through two of her ETFs. After the purchases, Ark Invest now owns a total of 9.96 million shares.2.Teradyne(TER)Teradyne(NASDAQ:TER) is an automatic test equipment designer that serves customers such as Intel(NASDAQ:INTC) and Qualcomm(NASDAQ:QCOM). The company helps customers automate two key aspects of manufacturing: task automation and electronic testing. The company’s task automation process utilizes collaborative robots to help automate tasks and deliver a fast return on investment (ROI). The electronics testing process helps companies reduce the time-to-market for products using automated test equipment (ATE).From July 18 to July 20, Wood purchased53,822 shares of TER through two of her ETFs. Ark Invest now owns a total of 497,048 shares.3. Ginkgo Bioworks(DNA)Ginkgo Bioworks(NYSE:DNA) is one of the few companies that Wood has been relentlessly buying through ARKK and the ARK Genomic Revolution ETF(BATS:ARKG). On July 18, the two ETFs scooped up a total of1.15 million shares. After the purchases, Ark Invest owns a total of 86.41 million shares, making it a top ten shareholder. Across all Ark ETFs, DNA is currently the 19th largest position with a 1.63% allocation.Ginkgo is a biotech company that specializes in genetic engineering. The company is involved with programming cells in a multitude of industries, ranging from food to therapeutics. This week, Ginkgo announced acollaborationwithSumitomoChemicals, a leading chemical company in Japan. Sumitomo will leverage Ginkgo’s engineering expertise and codebase to help improve products in several industries, such as the beauty and personal care industry.4.Trimble(TRMB)Trimble(NASDAQ:TRMB) provides software and hardware solutions across a variety of industries. The company employs workers in over 40 countries, while its solutions are used in over 150 countries. Additionally, TRMB carries an average price target of $88.29among seven firms with coverage of the stock. This implies upside of more than 35% from current price levels.From July 18 to July 20, Ark Invest purchased 70,734 shares of TRMB through two of its ETFs. This marks a major shift in trend, as Ark only sold shares of Trimble between Dec. 27 and May 2. After the purchases, Ark owns a total of 2.22 million shares.5. Twist Bioscience(TWST)Twist Bioscience(NASDAQ:TWST) is a DNA synthesis company that offers DNA products to customers in several industries. The company developed a proprietary synthetic DNA manufacturing process that allows it to “minimize” the chemistry used for DNA synthesis. The miniaturization allows Twist to “reduce the reaction volumes by a factor of 1,000,000 while increasing throughput by a factor of 1,000.” As a result, Twist’s DNA process translates into time and cost savings for its customers.On July 18, ARKK and ARKG purchased a total of 39,624 shares of TWST. After the purchases, Ark now owns a total of 6.59 million shares, making it the second largest shareholder behind FMR.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9077356679,"gmtCreate":1658457616791,"gmtModify":1676536162656,"author":{"id":"4091337845239220","authorId":"4091337845239220","name":"KhimTan","avatar":"https://static.tigerbbs.com/c95bc3062de0e56dc86bda97b6b4ba7f","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"4091337845239220","idStr":"4091337845239220"},"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9077356679","repostId":1167504690,"repostType":4,"repost":{"id":"1167504690","pubTimestamp":1658454795,"share":"https://ttm.financial/m/news/1167504690?lang=&edition=fundamental","pubTime":"2022-07-22 09:53","market":"us","language":"en","title":"5 Top Stocks Cathie Wood Bought This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1167504690","media":"InvestorPlace","summary":"Cathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchase","content":"<html><head></head><body><ul><li>Cathie Wood&#39;s stock purchases have largely outnumbered her sales this week.</li><li>The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).</li><li>Shares of her flagship ETF, the ARK Innovation ETF(ARKK), are down over 45% year-to-date.</li></ul>Shares of Cathie Wood’s flagship exchange-traded fund (ETF), the ARK Innovation ETF(NYSEARCA:ARKK), are up about 20% the past month. Despite the short term recovery, the ETF is still down more than 45% year-to-date. Cathie Wood stocks haven’t exactly beaten the market so far this year.In related news, the ARK Transparency ETF(BATS:CTRU) will officially be shutting down just eight months after its launch. However, the termination of the fund is not related to performance or a lack of popularity. Rather, the index that CTRU tracks, The Transparency Index, will cease to calculate performance at the end of the month. Ark Investstated that it had failed to find an alternative index to track. CTRU will close on July 26, or “as soon as practical thereafter.” This will be Ark’s first ever fund-closure.With that in mind, let’s take a look at five stocks that Cathie Wood bought this week.5 Top Stocks Cathie Wood Bought This Week1.Kratos Defense &amp; Security Solutions(KTOS)Kratos(NASDAQ:KTOS) operates as a national security company that develops weapons and communication and cybersecurity services for the U.S. and its allies. Unlike many other companies who are cutting their workforce, Kratos recently announced additional job openings at its facility in Birmingham, Alabama. The company also announced that it will invest $8.6 million at its Birmingham facility over the next five years. This investment will support advancements in hypersonic technology.From July 18 to July 20, Wood purchased219,011 shares of KTOS through two of her ETFs. After the purchases, Ark Invest now owns a total of 9.96 million shares.2.Teradyne(TER)Teradyne(NASDAQ:TER) is an automatic test equipment designer that serves customers such as Intel(NASDAQ:INTC) and Qualcomm(NASDAQ:QCOM). The company helps customers automate two key aspects of manufacturing: task automation and electronic testing. The company’s task automation process utilizes collaborative robots to help automate tasks and deliver a fast return on investment (ROI). The electronics testing process helps companies reduce the time-to-market for products using automated test equipment (ATE).From July 18 to July 20, Wood purchased53,822 shares of TER through two of her ETFs. Ark Invest now owns a total of 497,048 shares.3. Ginkgo Bioworks(DNA)Ginkgo Bioworks(NYSE:DNA) is one of the few companies that Wood has been relentlessly buying through ARKK and the ARK Genomic Revolution ETF(BATS:ARKG). On July 18, the two ETFs scooped up a total of1.15 million shares. After the purchases, Ark Invest owns a total of 86.41 million shares, making it a top ten shareholder. Across all Ark ETFs, DNA is currently the 19th largest position with a 1.63% allocation.Ginkgo is a biotech company that specializes in genetic engineering. The company is involved with programming cells in a multitude of industries, ranging from food to therapeutics. This week, Ginkgo announced acollaborationwithSumitomoChemicals, a leading chemical company in Japan. Sumitomo will leverage Ginkgo’s engineering expertise and codebase to help improve products in several industries, such as the beauty and personal care industry.4.Trimble(TRMB)Trimble(NASDAQ:TRMB) provides software and hardware solutions across a variety of industries. The company employs workers in over 40 countries, while its solutions are used in over 150 countries. Additionally, TRMB carries an average price target of $88.29among seven firms with coverage of the stock. This implies upside of more than 35% from current price levels.From July 18 to July 20, Ark Invest purchased 70,734 shares of TRMB through two of its ETFs. This marks a major shift in trend, as Ark only sold shares of Trimble between Dec. 27 and May 2. After the purchases, Ark owns a total of 2.22 million shares.5. Twist Bioscience(TWST)Twist Bioscience(NASDAQ:TWST) is a DNA synthesis company that offers DNA products to customers in several industries. The company developed a proprietary synthetic DNA manufacturing process that allows it to “minimize” the chemistry used for DNA synthesis. The miniaturization allows Twist to “reduce the reaction volumes by a factor of 1,000,000 while increasing throughput by a factor of 1,000.” As a result, Twist’s DNA process translates into time and cost savings for its customers.On July 18, ARKK and ARKG purchased a total of 39,624 shares of TWST. After the purchases, Ark now owns a total of 6.59 million shares, making it the second largest shareholder behind FMR.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Top Stocks Cathie Wood Bought This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Top Stocks Cathie Wood Bought This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-07-22 09:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nCathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ...\n\n<a href=\"https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TWST":"Twist Bioscience Corp","TER":"泰瑞达","KTOS":"克瑞拓斯安全防卫","TRMB":"天宝导航","DNA":"Ginkgo Bioworks Holdings Inc."},"source_url":"https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167504690","content_text":"Cathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ARK Innovation ETF(ARKK), are down over 45% year-to-date.Shares of Cathie Wood’s flagship exchange-traded fund (ETF), the ARK Innovation ETF(NYSEARCA:ARKK), are up about 20% the past month. Despite the short term recovery, the ETF is still down more than 45% year-to-date. Cathie Wood stocks haven’t exactly beaten the market so far this year.In related news, the ARK Transparency ETF(BATS:CTRU) will officially be shutting down just eight months after its launch. However, the termination of the fund is not related to performance or a lack of popularity. Rather, the index that CTRU tracks, The Transparency Index, will cease to calculate performance at the end of the month. Ark Investstated that it had failed to find an alternative index to track. CTRU will close on July 26, or “as soon as practical thereafter.” This will be Ark’s first ever fund-closure.With that in mind, let’s take a look at five stocks that Cathie Wood bought this week.5 Top Stocks Cathie Wood Bought This Week1.Kratos Defense & Security Solutions(KTOS)Kratos(NASDAQ:KTOS) operates as a national security company that develops weapons and communication and cybersecurity services for the U.S. and its allies. Unlike many other companies who are cutting their workforce, Kratos recently announced additional job openings at its facility in Birmingham, Alabama. The company also announced that it will invest $8.6 million at its Birmingham facility over the next five years. This investment will support advancements in hypersonic technology.From July 18 to July 20, Wood purchased219,011 shares of KTOS through two of her ETFs. After the purchases, Ark Invest now owns a total of 9.96 million shares.2.Teradyne(TER)Teradyne(NASDAQ:TER) is an automatic test equipment designer that serves customers such as Intel(NASDAQ:INTC) and Qualcomm(NASDAQ:QCOM). The company helps customers automate two key aspects of manufacturing: task automation and electronic testing. The company’s task automation process utilizes collaborative robots to help automate tasks and deliver a fast return on investment (ROI). The electronics testing process helps companies reduce the time-to-market for products using automated test equipment (ATE).From July 18 to July 20, Wood purchased53,822 shares of TER through two of her ETFs. Ark Invest now owns a total of 497,048 shares.3. Ginkgo Bioworks(DNA)Ginkgo Bioworks(NYSE:DNA) is one of the few companies that Wood has been relentlessly buying through ARKK and the ARK Genomic Revolution ETF(BATS:ARKG). On July 18, the two ETFs scooped up a total of1.15 million shares. After the purchases, Ark Invest owns a total of 86.41 million shares, making it a top ten shareholder. Across all Ark ETFs, DNA is currently the 19th largest position with a 1.63% allocation.Ginkgo is a biotech company that specializes in genetic engineering. The company is involved with programming cells in a multitude of industries, ranging from food to therapeutics. This week, Ginkgo announced acollaborationwithSumitomoChemicals, a leading chemical company in Japan. Sumitomo will leverage Ginkgo’s engineering expertise and codebase to help improve products in several industries, such as the beauty and personal care industry.4.Trimble(TRMB)Trimble(NASDAQ:TRMB) provides software and hardware solutions across a variety of industries. The company employs workers in over 40 countries, while its solutions are used in over 150 countries. Additionally, TRMB carries an average price target of $88.29among seven firms with coverage of the stock. This implies upside of more than 35% from current price levels.From July 18 to July 20, Ark Invest purchased 70,734 shares of TRMB through two of its ETFs. This marks a major shift in trend, as Ark only sold shares of Trimble between Dec. 27 and May 2. After the purchases, Ark owns a total of 2.22 million shares.5. Twist Bioscience(TWST)Twist Bioscience(NASDAQ:TWST) is a DNA synthesis company that offers DNA products to customers in several industries. The company developed a proprietary synthetic DNA manufacturing process that allows it to “minimize” the chemistry used for DNA synthesis. The miniaturization allows Twist to “reduce the reaction volumes by a factor of 1,000,000 while increasing throughput by a factor of 1,000.” As a result, Twist’s DNA process translates into time and cost savings for its customers.On July 18, ARKK and ARKG purchased a total of 39,624 shares of TWST. After the purchases, Ark now owns a total of 6.59 million shares, making it the second largest shareholder behind FMR.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9077356149,"gmtCreate":1658457593681,"gmtModify":1676536162648,"author":{"id":"4091337845239220","authorId":"4091337845239220","name":"KhimTan","avatar":"https://static.tigerbbs.com/c95bc3062de0e56dc86bda97b6b4ba7f","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"4091337845239220","idStr":"4091337845239220"},"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9077356149","repostId":1167504690,"repostType":4,"repost":{"id":"1167504690","pubTimestamp":1658454795,"share":"https://ttm.financial/m/news/1167504690?lang=&edition=fundamental","pubTime":"2022-07-22 09:53","market":"us","language":"en","title":"5 Top Stocks Cathie Wood Bought This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1167504690","media":"InvestorPlace","summary":"Cathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchase","content":"<html><head></head><body><ul><li>Cathie Wood&#39;s stock purchases have largely outnumbered her sales this week.</li><li>The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).</li><li>Shares of her flagship ETF, the ARK Innovation ETF(ARKK), are down over 45% year-to-date.</li></ul>Shares of Cathie Wood’s flagship exchange-traded fund (ETF), the ARK Innovation ETF(NYSEARCA:ARKK), are up about 20% the past month. Despite the short term recovery, the ETF is still down more than 45% year-to-date. Cathie Wood stocks haven’t exactly beaten the market so far this year.In related news, the ARK Transparency ETF(BATS:CTRU) will officially be shutting down just eight months after its launch. However, the termination of the fund is not related to performance or a lack of popularity. Rather, the index that CTRU tracks, The Transparency Index, will cease to calculate performance at the end of the month. Ark Investstated that it had failed to find an alternative index to track. CTRU will close on July 26, or “as soon as practical thereafter.” This will be Ark’s first ever fund-closure.With that in mind, let’s take a look at five stocks that Cathie Wood bought this week.5 Top Stocks Cathie Wood Bought This Week1.Kratos Defense &amp; Security Solutions(KTOS)Kratos(NASDAQ:KTOS) operates as a national security company that develops weapons and communication and cybersecurity services for the U.S. and its allies. Unlike many other companies who are cutting their workforce, Kratos recently announced additional job openings at its facility in Birmingham, Alabama. The company also announced that it will invest $8.6 million at its Birmingham facility over the next five years. This investment will support advancements in hypersonic technology.From July 18 to July 20, Wood purchased219,011 shares of KTOS through two of her ETFs. After the purchases, Ark Invest now owns a total of 9.96 million shares.2.Teradyne(TER)Teradyne(NASDAQ:TER) is an automatic test equipment designer that serves customers such as Intel(NASDAQ:INTC) and Qualcomm(NASDAQ:QCOM). The company helps customers automate two key aspects of manufacturing: task automation and electronic testing. The company’s task automation process utilizes collaborative robots to help automate tasks and deliver a fast return on investment (ROI). The electronics testing process helps companies reduce the time-to-market for products using automated test equipment (ATE).From July 18 to July 20, Wood purchased53,822 shares of TER through two of her ETFs. Ark Invest now owns a total of 497,048 shares.3. Ginkgo Bioworks(DNA)Ginkgo Bioworks(NYSE:DNA) is one of the few companies that Wood has been relentlessly buying through ARKK and the ARK Genomic Revolution ETF(BATS:ARKG). On July 18, the two ETFs scooped up a total of1.15 million shares. After the purchases, Ark Invest owns a total of 86.41 million shares, making it a top ten shareholder. Across all Ark ETFs, DNA is currently the 19th largest position with a 1.63% allocation.Ginkgo is a biotech company that specializes in genetic engineering. The company is involved with programming cells in a multitude of industries, ranging from food to therapeutics. This week, Ginkgo announced acollaborationwithSumitomoChemicals, a leading chemical company in Japan. Sumitomo will leverage Ginkgo’s engineering expertise and codebase to help improve products in several industries, such as the beauty and personal care industry.4.Trimble(TRMB)Trimble(NASDAQ:TRMB) provides software and hardware solutions across a variety of industries. The company employs workers in over 40 countries, while its solutions are used in over 150 countries. Additionally, TRMB carries an average price target of $88.29among seven firms with coverage of the stock. This implies upside of more than 35% from current price levels.From July 18 to July 20, Ark Invest purchased 70,734 shares of TRMB through two of its ETFs. This marks a major shift in trend, as Ark only sold shares of Trimble between Dec. 27 and May 2. After the purchases, Ark owns a total of 2.22 million shares.5. Twist Bioscience(TWST)Twist Bioscience(NASDAQ:TWST) is a DNA synthesis company that offers DNA products to customers in several industries. The company developed a proprietary synthetic DNA manufacturing process that allows it to “minimize” the chemistry used for DNA synthesis. The miniaturization allows Twist to “reduce the reaction volumes by a factor of 1,000,000 while increasing throughput by a factor of 1,000.” As a result, Twist’s DNA process translates into time and cost savings for its customers.On July 18, ARKK and ARKG purchased a total of 39,624 shares of TWST. After the purchases, Ark now owns a total of 6.59 million shares, making it the second largest shareholder behind FMR.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Top Stocks Cathie Wood Bought This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Top Stocks Cathie Wood Bought This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-07-22 09:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nCathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ...\n\n<a href=\"https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TWST":"Twist Bioscience Corp","TER":"泰瑞达","KTOS":"克瑞拓斯安全防卫","TRMB":"天宝导航","DNA":"Ginkgo Bioworks Holdings Inc."},"source_url":"https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167504690","content_text":"Cathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ARK Innovation ETF(ARKK), are down over 45% year-to-date.Shares of Cathie Wood’s flagship exchange-traded fund (ETF), the ARK Innovation ETF(NYSEARCA:ARKK), are up about 20% the past month. Despite the short term recovery, the ETF is still down more than 45% year-to-date. Cathie Wood stocks haven’t exactly beaten the market so far this year.In related news, the ARK Transparency ETF(BATS:CTRU) will officially be shutting down just eight months after its launch. However, the termination of the fund is not related to performance or a lack of popularity. Rather, the index that CTRU tracks, The Transparency Index, will cease to calculate performance at the end of the month. Ark Investstated that it had failed to find an alternative index to track. CTRU will close on July 26, or “as soon as practical thereafter.” This will be Ark’s first ever fund-closure.With that in mind, let’s take a look at five stocks that Cathie Wood bought this week.5 Top Stocks Cathie Wood Bought This Week1.Kratos Defense & Security Solutions(KTOS)Kratos(NASDAQ:KTOS) operates as a national security company that develops weapons and communication and cybersecurity services for the U.S. and its allies. Unlike many other companies who are cutting their workforce, Kratos recently announced additional job openings at its facility in Birmingham, Alabama. The company also announced that it will invest $8.6 million at its Birmingham facility over the next five years. This investment will support advancements in hypersonic technology.From July 18 to July 20, Wood purchased219,011 shares of KTOS through two of her ETFs. After the purchases, Ark Invest now owns a total of 9.96 million shares.2.Teradyne(TER)Teradyne(NASDAQ:TER) is an automatic test equipment designer that serves customers such as Intel(NASDAQ:INTC) and Qualcomm(NASDAQ:QCOM). The company helps customers automate two key aspects of manufacturing: task automation and electronic testing. The company’s task automation process utilizes collaborative robots to help automate tasks and deliver a fast return on investment (ROI). The electronics testing process helps companies reduce the time-to-market for products using automated test equipment (ATE).From July 18 to July 20, Wood purchased53,822 shares of TER through two of her ETFs. Ark Invest now owns a total of 497,048 shares.3. Ginkgo Bioworks(DNA)Ginkgo Bioworks(NYSE:DNA) is one of the few companies that Wood has been relentlessly buying through ARKK and the ARK Genomic Revolution ETF(BATS:ARKG). On July 18, the two ETFs scooped up a total of1.15 million shares. After the purchases, Ark Invest owns a total of 86.41 million shares, making it a top ten shareholder. Across all Ark ETFs, DNA is currently the 19th largest position with a 1.63% allocation.Ginkgo is a biotech company that specializes in genetic engineering. The company is involved with programming cells in a multitude of industries, ranging from food to therapeutics. This week, Ginkgo announced acollaborationwithSumitomoChemicals, a leading chemical company in Japan. Sumitomo will leverage Ginkgo’s engineering expertise and codebase to help improve products in several industries, such as the beauty and personal care industry.4.Trimble(TRMB)Trimble(NASDAQ:TRMB) provides software and hardware solutions across a variety of industries. The company employs workers in over 40 countries, while its solutions are used in over 150 countries. Additionally, TRMB carries an average price target of $88.29among seven firms with coverage of the stock. This implies upside of more than 35% from current price levels.From July 18 to July 20, Ark Invest purchased 70,734 shares of TRMB through two of its ETFs. This marks a major shift in trend, as Ark only sold shares of Trimble between Dec. 27 and May 2. After the purchases, Ark owns a total of 2.22 million shares.5. Twist Bioscience(TWST)Twist Bioscience(NASDAQ:TWST) is a DNA synthesis company that offers DNA products to customers in several industries. The company developed a proprietary synthetic DNA manufacturing process that allows it to “minimize” the chemistry used for DNA synthesis. The miniaturization allows Twist to “reduce the reaction volumes by a factor of 1,000,000 while increasing throughput by a factor of 1,000.” As a result, Twist’s DNA process translates into time and cost savings for its customers.On July 18, ARKK and ARKG purchased a total of 39,624 shares of TWST. After the purchases, Ark now owns a total of 6.59 million shares, making it the second largest shareholder behind FMR.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9077358435,"gmtCreate":1658457531928,"gmtModify":1676536162640,"author":{"id":"3573374991554107","authorId":"3573374991554107","name":"sinoob","avatar":"https://static.tigerbbs.com/c7aa6e79d10d30e6c542fe5787c2a09d","vip":1,"hat":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":3,"crmLevelSwitch":1,"authorIdStr":"3573374991554107","idStr":"3573374991554107"},"htmlText":"Tgif!!! Come like like comment comment tqtq kamsahamida arigato&nbsp;","listText":"Tgif!!! Come like like comment comment tqtq kamsahamida arigato&nbsp;","text":"Tgif!!! Come like like comment comment tqtq kamsahamida arigato","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9077358435","repostId":1167504690,"repostType":4,"repost":{"id":"1167504690","pubTimestamp":1658454795,"share":"https://ttm.financial/m/news/1167504690?lang=&edition=fundamental","pubTime":"2022-07-22 09:53","market":"us","language":"en","title":"5 Top Stocks Cathie Wood Bought This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1167504690","media":"InvestorPlace","summary":"Cathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchase","content":"<html><head></head><body><ul><li>Cathie Wood&#39;s stock purchases have largely outnumbered her sales this week.</li><li>The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).</li><li>Shares of her flagship ETF, the ARK Innovation ETF(ARKK), are down over 45% year-to-date.</li></ul>Shares of Cathie Wood’s flagship exchange-traded fund (ETF), the ARK Innovation ETF(NYSEARCA:ARKK), are up about 20% the past month. Despite the short term recovery, the ETF is still down more than 45% year-to-date. Cathie Wood stocks haven’t exactly beaten the market so far this year.In related news, the ARK Transparency ETF(BATS:CTRU) will officially be shutting down just eight months after its launch. However, the termination of the fund is not related to performance or a lack of popularity. Rather, the index that CTRU tracks, The Transparency Index, will cease to calculate performance at the end of the month. Ark Investstated that it had failed to find an alternative index to track. CTRU will close on July 26, or “as soon as practical thereafter.” This will be Ark’s first ever fund-closure.With that in mind, let’s take a look at five stocks that Cathie Wood bought this week.5 Top Stocks Cathie Wood Bought This Week1.Kratos Defense &amp; Security Solutions(KTOS)Kratos(NASDAQ:KTOS) operates as a national security company that develops weapons and communication and cybersecurity services for the U.S. and its allies. Unlike many other companies who are cutting their workforce, Kratos recently announced additional job openings at its facility in Birmingham, Alabama. The company also announced that it will invest $8.6 million at its Birmingham facility over the next five years. This investment will support advancements in hypersonic technology.From July 18 to July 20, Wood purchased219,011 shares of KTOS through two of her ETFs. After the purchases, Ark Invest now owns a total of 9.96 million shares.2.Teradyne(TER)Teradyne(NASDAQ:TER) is an automatic test equipment designer that serves customers such as Intel(NASDAQ:INTC) and Qualcomm(NASDAQ:QCOM). The company helps customers automate two key aspects of manufacturing: task automation and electronic testing. The company’s task automation process utilizes collaborative robots to help automate tasks and deliver a fast return on investment (ROI). The electronics testing process helps companies reduce the time-to-market for products using automated test equipment (ATE).From July 18 to July 20, Wood purchased53,822 shares of TER through two of her ETFs. Ark Invest now owns a total of 497,048 shares.3. Ginkgo Bioworks(DNA)Ginkgo Bioworks(NYSE:DNA) is one of the few companies that Wood has been relentlessly buying through ARKK and the ARK Genomic Revolution ETF(BATS:ARKG). On July 18, the two ETFs scooped up a total of1.15 million shares. After the purchases, Ark Invest owns a total of 86.41 million shares, making it a top ten shareholder. Across all Ark ETFs, DNA is currently the 19th largest position with a 1.63% allocation.Ginkgo is a biotech company that specializes in genetic engineering. The company is involved with programming cells in a multitude of industries, ranging from food to therapeutics. This week, Ginkgo announced acollaborationwithSumitomoChemicals, a leading chemical company in Japan. Sumitomo will leverage Ginkgo’s engineering expertise and codebase to help improve products in several industries, such as the beauty and personal care industry.4.Trimble(TRMB)Trimble(NASDAQ:TRMB) provides software and hardware solutions across a variety of industries. The company employs workers in over 40 countries, while its solutions are used in over 150 countries. Additionally, TRMB carries an average price target of $88.29among seven firms with coverage of the stock. This implies upside of more than 35% from current price levels.From July 18 to July 20, Ark Invest purchased 70,734 shares of TRMB through two of its ETFs. This marks a major shift in trend, as Ark only sold shares of Trimble between Dec. 27 and May 2. After the purchases, Ark owns a total of 2.22 million shares.5. Twist Bioscience(TWST)Twist Bioscience(NASDAQ:TWST) is a DNA synthesis company that offers DNA products to customers in several industries. The company developed a proprietary synthetic DNA manufacturing process that allows it to “minimize” the chemistry used for DNA synthesis. The miniaturization allows Twist to “reduce the reaction volumes by a factor of 1,000,000 while increasing throughput by a factor of 1,000.” As a result, Twist’s DNA process translates into time and cost savings for its customers.On July 18, ARKK and ARKG purchased a total of 39,624 shares of TWST. After the purchases, Ark now owns a total of 6.59 million shares, making it the second largest shareholder behind FMR.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Top Stocks Cathie Wood Bought This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Top Stocks Cathie Wood Bought This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-07-22 09:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nCathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ...\n\n<a href=\"https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TWST":"Twist Bioscience Corp","TER":"泰瑞达","KTOS":"克瑞拓斯安全防卫","TRMB":"天宝导航","DNA":"Ginkgo Bioworks Holdings Inc."},"source_url":"https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167504690","content_text":"Cathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ARK Innovation ETF(ARKK), are down over 45% year-to-date.Shares of Cathie Wood’s flagship exchange-traded fund (ETF), the ARK Innovation ETF(NYSEARCA:ARKK), are up about 20% the past month. Despite the short term recovery, the ETF is still down more than 45% year-to-date. Cathie Wood stocks haven’t exactly beaten the market so far this year.In related news, the ARK Transparency ETF(BATS:CTRU) will officially be shutting down just eight months after its launch. However, the termination of the fund is not related to performance or a lack of popularity. Rather, the index that CTRU tracks, The Transparency Index, will cease to calculate performance at the end of the month. Ark Investstated that it had failed to find an alternative index to track. CTRU will close on July 26, or “as soon as practical thereafter.” This will be Ark’s first ever fund-closure.With that in mind, let’s take a look at five stocks that Cathie Wood bought this week.5 Top Stocks Cathie Wood Bought This Week1.Kratos Defense & Security Solutions(KTOS)Kratos(NASDAQ:KTOS) operates as a national security company that develops weapons and communication and cybersecurity services for the U.S. and its allies. Unlike many other companies who are cutting their workforce, Kratos recently announced additional job openings at its facility in Birmingham, Alabama. The company also announced that it will invest $8.6 million at its Birmingham facility over the next five years. This investment will support advancements in hypersonic technology.From July 18 to July 20, Wood purchased219,011 shares of KTOS through two of her ETFs. After the purchases, Ark Invest now owns a total of 9.96 million shares.2.Teradyne(TER)Teradyne(NASDAQ:TER) is an automatic test equipment designer that serves customers such as Intel(NASDAQ:INTC) and Qualcomm(NASDAQ:QCOM). The company helps customers automate two key aspects of manufacturing: task automation and electronic testing. The company’s task automation process utilizes collaborative robots to help automate tasks and deliver a fast return on investment (ROI). The electronics testing process helps companies reduce the time-to-market for products using automated test equipment (ATE).From July 18 to July 20, Wood purchased53,822 shares of TER through two of her ETFs. Ark Invest now owns a total of 497,048 shares.3. Ginkgo Bioworks(DNA)Ginkgo Bioworks(NYSE:DNA) is one of the few companies that Wood has been relentlessly buying through ARKK and the ARK Genomic Revolution ETF(BATS:ARKG). On July 18, the two ETFs scooped up a total of1.15 million shares. After the purchases, Ark Invest owns a total of 86.41 million shares, making it a top ten shareholder. Across all Ark ETFs, DNA is currently the 19th largest position with a 1.63% allocation.Ginkgo is a biotech company that specializes in genetic engineering. The company is involved with programming cells in a multitude of industries, ranging from food to therapeutics. This week, Ginkgo announced acollaborationwithSumitomoChemicals, a leading chemical company in Japan. Sumitomo will leverage Ginkgo’s engineering expertise and codebase to help improve products in several industries, such as the beauty and personal care industry.4.Trimble(TRMB)Trimble(NASDAQ:TRMB) provides software and hardware solutions across a variety of industries. The company employs workers in over 40 countries, while its solutions are used in over 150 countries. Additionally, TRMB carries an average price target of $88.29among seven firms with coverage of the stock. This implies upside of more than 35% from current price levels.From July 18 to July 20, Ark Invest purchased 70,734 shares of TRMB through two of its ETFs. This marks a major shift in trend, as Ark only sold shares of Trimble between Dec. 27 and May 2. After the purchases, Ark owns a total of 2.22 million shares.5. Twist Bioscience(TWST)Twist Bioscience(NASDAQ:TWST) is a DNA synthesis company that offers DNA products to customers in several industries. The company developed a proprietary synthetic DNA manufacturing process that allows it to “minimize” the chemistry used for DNA synthesis. The miniaturization allows Twist to “reduce the reaction volumes by a factor of 1,000,000 while increasing throughput by a factor of 1,000.” As a result, Twist’s DNA process translates into time and cost savings for its customers.On July 18, ARKK and ARKG purchased a total of 39,624 shares of TWST. After the purchases, Ark now owns a total of 6.59 million shares, making it the second largest shareholder behind FMR.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9077358279,"gmtCreate":1658457510391,"gmtModify":1676536162633,"author":{"id":"3571015317722951","authorId":"3571015317722951","name":"jejesss","avatar":"https://static.tigerbbs.com/198a6a4d807d473d73a6f152624c1a23","vip":1,"hat":"https://static.tigerbbs.com/f84d87792f02cf78e80ee34979fd31e5","crmLevel":6,"crmLevelSwitch":0,"authorIdStr":"3571015317722951","idStr":"3571015317722951"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9077358279","repostId":1167504690,"repostType":4,"repost":{"id":"1167504690","pubTimestamp":1658454795,"share":"https://ttm.financial/m/news/1167504690?lang=&edition=fundamental","pubTime":"2022-07-22 09:53","market":"us","language":"en","title":"5 Top Stocks Cathie Wood Bought This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1167504690","media":"InvestorPlace","summary":"Cathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchase","content":"<html><head></head><body><ul><li>Cathie Wood&#39;s stock purchases have largely outnumbered her sales this week.</li><li>The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).</li><li>Shares of her flagship ETF, the ARK Innovation ETF(ARKK), are down over 45% year-to-date.</li></ul>Shares of Cathie Wood’s flagship exchange-traded fund (ETF), the ARK Innovation ETF(NYSEARCA:ARKK), are up about 20% the past month. Despite the short term recovery, the ETF is still down more than 45% year-to-date. Cathie Wood stocks haven’t exactly beaten the market so far this year.In related news, the ARK Transparency ETF(BATS:CTRU) will officially be shutting down just eight months after its launch. However, the termination of the fund is not related to performance or a lack of popularity. Rather, the index that CTRU tracks, The Transparency Index, will cease to calculate performance at the end of the month. Ark Investstated that it had failed to find an alternative index to track. CTRU will close on July 26, or “as soon as practical thereafter.” This will be Ark’s first ever fund-closure.With that in mind, let’s take a look at five stocks that Cathie Wood bought this week.5 Top Stocks Cathie Wood Bought This Week1.Kratos Defense &amp; Security Solutions(KTOS)Kratos(NASDAQ:KTOS) operates as a national security company that develops weapons and communication and cybersecurity services for the U.S. and its allies. Unlike many other companies who are cutting their workforce, Kratos recently announced additional job openings at its facility in Birmingham, Alabama. The company also announced that it will invest $8.6 million at its Birmingham facility over the next five years. This investment will support advancements in hypersonic technology.From July 18 to July 20, Wood purchased219,011 shares of KTOS through two of her ETFs. After the purchases, Ark Invest now owns a total of 9.96 million shares.2.Teradyne(TER)Teradyne(NASDAQ:TER) is an automatic test equipment designer that serves customers such as Intel(NASDAQ:INTC) and Qualcomm(NASDAQ:QCOM). The company helps customers automate two key aspects of manufacturing: task automation and electronic testing. The company’s task automation process utilizes collaborative robots to help automate tasks and deliver a fast return on investment (ROI). The electronics testing process helps companies reduce the time-to-market for products using automated test equipment (ATE).From July 18 to July 20, Wood purchased53,822 shares of TER through two of her ETFs. Ark Invest now owns a total of 497,048 shares.3. Ginkgo Bioworks(DNA)Ginkgo Bioworks(NYSE:DNA) is one of the few companies that Wood has been relentlessly buying through ARKK and the ARK Genomic Revolution ETF(BATS:ARKG). On July 18, the two ETFs scooped up a total of1.15 million shares. After the purchases, Ark Invest owns a total of 86.41 million shares, making it a top ten shareholder. Across all Ark ETFs, DNA is currently the 19th largest position with a 1.63% allocation.Ginkgo is a biotech company that specializes in genetic engineering. The company is involved with programming cells in a multitude of industries, ranging from food to therapeutics. This week, Ginkgo announced acollaborationwithSumitomoChemicals, a leading chemical company in Japan. Sumitomo will leverage Ginkgo’s engineering expertise and codebase to help improve products in several industries, such as the beauty and personal care industry.4.Trimble(TRMB)Trimble(NASDAQ:TRMB) provides software and hardware solutions across a variety of industries. The company employs workers in over 40 countries, while its solutions are used in over 150 countries. Additionally, TRMB carries an average price target of $88.29among seven firms with coverage of the stock. This implies upside of more than 35% from current price levels.From July 18 to July 20, Ark Invest purchased 70,734 shares of TRMB through two of its ETFs. This marks a major shift in trend, as Ark only sold shares of Trimble between Dec. 27 and May 2. After the purchases, Ark owns a total of 2.22 million shares.5. Twist Bioscience(TWST)Twist Bioscience(NASDAQ:TWST) is a DNA synthesis company that offers DNA products to customers in several industries. The company developed a proprietary synthetic DNA manufacturing process that allows it to “minimize” the chemistry used for DNA synthesis. The miniaturization allows Twist to “reduce the reaction volumes by a factor of 1,000,000 while increasing throughput by a factor of 1,000.” As a result, Twist’s DNA process translates into time and cost savings for its customers.On July 18, ARKK and ARKG purchased a total of 39,624 shares of TWST. After the purchases, Ark now owns a total of 6.59 million shares, making it the second largest shareholder behind FMR.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Top Stocks Cathie Wood Bought This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Top Stocks Cathie Wood Bought This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-07-22 09:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nCathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ...\n\n<a href=\"https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TWST":"Twist Bioscience Corp","TER":"泰瑞达","KTOS":"克瑞拓斯安全防卫","TRMB":"天宝导航","DNA":"Ginkgo Bioworks Holdings Inc."},"source_url":"https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167504690","content_text":"Cathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ARK Innovation ETF(ARKK), are down over 45% year-to-date.Shares of Cathie Wood’s flagship exchange-traded fund (ETF), the ARK Innovation ETF(NYSEARCA:ARKK), are up about 20% the past month. Despite the short term recovery, the ETF is still down more than 45% year-to-date. Cathie Wood stocks haven’t exactly beaten the market so far this year.In related news, the ARK Transparency ETF(BATS:CTRU) will officially be shutting down just eight months after its launch. However, the termination of the fund is not related to performance or a lack of popularity. Rather, the index that CTRU tracks, The Transparency Index, will cease to calculate performance at the end of the month. Ark Investstated that it had failed to find an alternative index to track. CTRU will close on July 26, or “as soon as practical thereafter.” This will be Ark’s first ever fund-closure.With that in mind, let’s take a look at five stocks that Cathie Wood bought this week.5 Top Stocks Cathie Wood Bought This Week1.Kratos Defense & Security Solutions(KTOS)Kratos(NASDAQ:KTOS) operates as a national security company that develops weapons and communication and cybersecurity services for the U.S. and its allies. Unlike many other companies who are cutting their workforce, Kratos recently announced additional job openings at its facility in Birmingham, Alabama. The company also announced that it will invest $8.6 million at its Birmingham facility over the next five years. This investment will support advancements in hypersonic technology.From July 18 to July 20, Wood purchased219,011 shares of KTOS through two of her ETFs. After the purchases, Ark Invest now owns a total of 9.96 million shares.2.Teradyne(TER)Teradyne(NASDAQ:TER) is an automatic test equipment designer that serves customers such as Intel(NASDAQ:INTC) and Qualcomm(NASDAQ:QCOM). The company helps customers automate two key aspects of manufacturing: task automation and electronic testing. The company’s task automation process utilizes collaborative robots to help automate tasks and deliver a fast return on investment (ROI). The electronics testing process helps companies reduce the time-to-market for products using automated test equipment (ATE).From July 18 to July 20, Wood purchased53,822 shares of TER through two of her ETFs. Ark Invest now owns a total of 497,048 shares.3. Ginkgo Bioworks(DNA)Ginkgo Bioworks(NYSE:DNA) is one of the few companies that Wood has been relentlessly buying through ARKK and the ARK Genomic Revolution ETF(BATS:ARKG). On July 18, the two ETFs scooped up a total of1.15 million shares. After the purchases, Ark Invest owns a total of 86.41 million shares, making it a top ten shareholder. Across all Ark ETFs, DNA is currently the 19th largest position with a 1.63% allocation.Ginkgo is a biotech company that specializes in genetic engineering. The company is involved with programming cells in a multitude of industries, ranging from food to therapeutics. This week, Ginkgo announced acollaborationwithSumitomoChemicals, a leading chemical company in Japan. Sumitomo will leverage Ginkgo’s engineering expertise and codebase to help improve products in several industries, such as the beauty and personal care industry.4.Trimble(TRMB)Trimble(NASDAQ:TRMB) provides software and hardware solutions across a variety of industries. The company employs workers in over 40 countries, while its solutions are used in over 150 countries. Additionally, TRMB carries an average price target of $88.29among seven firms with coverage of the stock. This implies upside of more than 35% from current price levels.From July 18 to July 20, Ark Invest purchased 70,734 shares of TRMB through two of its ETFs. This marks a major shift in trend, as Ark only sold shares of Trimble between Dec. 27 and May 2. After the purchases, Ark owns a total of 2.22 million shares.5. Twist Bioscience(TWST)Twist Bioscience(NASDAQ:TWST) is a DNA synthesis company that offers DNA products to customers in several industries. The company developed a proprietary synthetic DNA manufacturing process that allows it to “minimize” the chemistry used for DNA synthesis. The miniaturization allows Twist to “reduce the reaction volumes by a factor of 1,000,000 while increasing throughput by a factor of 1,000.” As a result, Twist’s DNA process translates into time and cost savings for its customers.On July 18, ARKK and ARKG purchased a total of 39,624 shares of TWST. After the purchases, Ark now owns a total of 6.59 million shares, making it the second largest shareholder behind FMR.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9077351278,"gmtCreate":1658457419494,"gmtModify":1676536162610,"author":{"id":"3572043809285615","authorId":"3572043809285615","name":"NP_YT","avatar":"https://static.itradeup.com/news/fad9f70abb174e3e09e4caf3f9c0c13a","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3572043809285615","idStr":"3572043809285615"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9077351278","repostId":1167504690,"repostType":4,"repost":{"id":"1167504690","pubTimestamp":1658454795,"share":"https://ttm.financial/m/news/1167504690?lang=&edition=fundamental","pubTime":"2022-07-22 09:53","market":"us","language":"en","title":"5 Top Stocks Cathie Wood Bought This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1167504690","media":"InvestorPlace","summary":"Cathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchase","content":"<html><head></head><body><ul><li>Cathie Wood&#39;s stock purchases have largely outnumbered her sales this week.</li><li>The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).</li><li>Shares of her flagship ETF, the ARK Innovation ETF(ARKK), are down over 45% year-to-date.</li></ul>Shares of Cathie Wood’s flagship exchange-traded fund (ETF), the ARK Innovation ETF(NYSEARCA:ARKK), are up about 20% the past month. Despite the short term recovery, the ETF is still down more than 45% year-to-date. Cathie Wood stocks haven’t exactly beaten the market so far this year.In related news, the ARK Transparency ETF(BATS:CTRU) will officially be shutting down just eight months after its launch. However, the termination of the fund is not related to performance or a lack of popularity. Rather, the index that CTRU tracks, The Transparency Index, will cease to calculate performance at the end of the month. Ark Investstated that it had failed to find an alternative index to track. CTRU will close on July 26, or “as soon as practical thereafter.” This will be Ark’s first ever fund-closure.With that in mind, let’s take a look at five stocks that Cathie Wood bought this week.5 Top Stocks Cathie Wood Bought This Week1.Kratos Defense &amp; Security Solutions(KTOS)Kratos(NASDAQ:KTOS) operates as a national security company that develops weapons and communication and cybersecurity services for the U.S. and its allies. Unlike many other companies who are cutting their workforce, Kratos recently announced additional job openings at its facility in Birmingham, Alabama. The company also announced that it will invest $8.6 million at its Birmingham facility over the next five years. This investment will support advancements in hypersonic technology.From July 18 to July 20, Wood purchased219,011 shares of KTOS through two of her ETFs. After the purchases, Ark Invest now owns a total of 9.96 million shares.2.Teradyne(TER)Teradyne(NASDAQ:TER) is an automatic test equipment designer that serves customers such as Intel(NASDAQ:INTC) and Qualcomm(NASDAQ:QCOM). The company helps customers automate two key aspects of manufacturing: task automation and electronic testing. The company’s task automation process utilizes collaborative robots to help automate tasks and deliver a fast return on investment (ROI). The electronics testing process helps companies reduce the time-to-market for products using automated test equipment (ATE).From July 18 to July 20, Wood purchased53,822 shares of TER through two of her ETFs. Ark Invest now owns a total of 497,048 shares.3. Ginkgo Bioworks(DNA)Ginkgo Bioworks(NYSE:DNA) is one of the few companies that Wood has been relentlessly buying through ARKK and the ARK Genomic Revolution ETF(BATS:ARKG). On July 18, the two ETFs scooped up a total of1.15 million shares. After the purchases, Ark Invest owns a total of 86.41 million shares, making it a top ten shareholder. Across all Ark ETFs, DNA is currently the 19th largest position with a 1.63% allocation.Ginkgo is a biotech company that specializes in genetic engineering. The company is involved with programming cells in a multitude of industries, ranging from food to therapeutics. This week, Ginkgo announced acollaborationwithSumitomoChemicals, a leading chemical company in Japan. Sumitomo will leverage Ginkgo’s engineering expertise and codebase to help improve products in several industries, such as the beauty and personal care industry.4.Trimble(TRMB)Trimble(NASDAQ:TRMB) provides software and hardware solutions across a variety of industries. The company employs workers in over 40 countries, while its solutions are used in over 150 countries. Additionally, TRMB carries an average price target of $88.29among seven firms with coverage of the stock. This implies upside of more than 35% from current price levels.From July 18 to July 20, Ark Invest purchased 70,734 shares of TRMB through two of its ETFs. This marks a major shift in trend, as Ark only sold shares of Trimble between Dec. 27 and May 2. After the purchases, Ark owns a total of 2.22 million shares.5. Twist Bioscience(TWST)Twist Bioscience(NASDAQ:TWST) is a DNA synthesis company that offers DNA products to customers in several industries. The company developed a proprietary synthetic DNA manufacturing process that allows it to “minimize” the chemistry used for DNA synthesis. The miniaturization allows Twist to “reduce the reaction volumes by a factor of 1,000,000 while increasing throughput by a factor of 1,000.” As a result, Twist’s DNA process translates into time and cost savings for its customers.On July 18, ARKK and ARKG purchased a total of 39,624 shares of TWST. After the purchases, Ark now owns a total of 6.59 million shares, making it the second largest shareholder behind FMR.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Top Stocks Cathie Wood Bought This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Top Stocks Cathie Wood Bought This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-07-22 09:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nCathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ...\n\n<a href=\"https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TWST":"Twist Bioscience Corp","TER":"泰瑞达","KTOS":"克瑞拓斯安全防卫","TRMB":"天宝导航","DNA":"Ginkgo Bioworks Holdings Inc."},"source_url":"https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167504690","content_text":"Cathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ARK Innovation ETF(ARKK), are down over 45% year-to-date.Shares of Cathie Wood’s flagship exchange-traded fund (ETF), the ARK Innovation ETF(NYSEARCA:ARKK), are up about 20% the past month. Despite the short term recovery, the ETF is still down more than 45% year-to-date. Cathie Wood stocks haven’t exactly beaten the market so far this year.In related news, the ARK Transparency ETF(BATS:CTRU) will officially be shutting down just eight months after its launch. However, the termination of the fund is not related to performance or a lack of popularity. Rather, the index that CTRU tracks, The Transparency Index, will cease to calculate performance at the end of the month. Ark Investstated that it had failed to find an alternative index to track. CTRU will close on July 26, or “as soon as practical thereafter.” This will be Ark’s first ever fund-closure.With that in mind, let’s take a look at five stocks that Cathie Wood bought this week.5 Top Stocks Cathie Wood Bought This Week1.Kratos Defense & Security Solutions(KTOS)Kratos(NASDAQ:KTOS) operates as a national security company that develops weapons and communication and cybersecurity services for the U.S. and its allies. Unlike many other companies who are cutting their workforce, Kratos recently announced additional job openings at its facility in Birmingham, Alabama. The company also announced that it will invest $8.6 million at its Birmingham facility over the next five years. This investment will support advancements in hypersonic technology.From July 18 to July 20, Wood purchased219,011 shares of KTOS through two of her ETFs. After the purchases, Ark Invest now owns a total of 9.96 million shares.2.Teradyne(TER)Teradyne(NASDAQ:TER) is an automatic test equipment designer that serves customers such as Intel(NASDAQ:INTC) and Qualcomm(NASDAQ:QCOM). The company helps customers automate two key aspects of manufacturing: task automation and electronic testing. The company’s task automation process utilizes collaborative robots to help automate tasks and deliver a fast return on investment (ROI). The electronics testing process helps companies reduce the time-to-market for products using automated test equipment (ATE).From July 18 to July 20, Wood purchased53,822 shares of TER through two of her ETFs. Ark Invest now owns a total of 497,048 shares.3. Ginkgo Bioworks(DNA)Ginkgo Bioworks(NYSE:DNA) is one of the few companies that Wood has been relentlessly buying through ARKK and the ARK Genomic Revolution ETF(BATS:ARKG). On July 18, the two ETFs scooped up a total of1.15 million shares. After the purchases, Ark Invest owns a total of 86.41 million shares, making it a top ten shareholder. Across all Ark ETFs, DNA is currently the 19th largest position with a 1.63% allocation.Ginkgo is a biotech company that specializes in genetic engineering. The company is involved with programming cells in a multitude of industries, ranging from food to therapeutics. This week, Ginkgo announced acollaborationwithSumitomoChemicals, a leading chemical company in Japan. Sumitomo will leverage Ginkgo’s engineering expertise and codebase to help improve products in several industries, such as the beauty and personal care industry.4.Trimble(TRMB)Trimble(NASDAQ:TRMB) provides software and hardware solutions across a variety of industries. The company employs workers in over 40 countries, while its solutions are used in over 150 countries. Additionally, TRMB carries an average price target of $88.29among seven firms with coverage of the stock. This implies upside of more than 35% from current price levels.From July 18 to July 20, Ark Invest purchased 70,734 shares of TRMB through two of its ETFs. This marks a major shift in trend, as Ark only sold shares of Trimble between Dec. 27 and May 2. After the purchases, Ark owns a total of 2.22 million shares.5. Twist Bioscience(TWST)Twist Bioscience(NASDAQ:TWST) is a DNA synthesis company that offers DNA products to customers in several industries. The company developed a proprietary synthetic DNA manufacturing process that allows it to “minimize” the chemistry used for DNA synthesis. The miniaturization allows Twist to “reduce the reaction volumes by a factor of 1,000,000 while increasing throughput by a factor of 1,000.” As a result, Twist’s DNA process translates into time and cost savings for its customers.On July 18, ARKK and ARKG purchased a total of 39,624 shares of TWST. After the purchases, Ark now owns a total of 6.59 million shares, making it the second largest shareholder behind FMR.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9077351985,"gmtCreate":1658457353047,"gmtModify":1676536162594,"author":{"id":"3586987359612845","authorId":"3586987359612845","name":"yingyingzoe","avatar":"https://static.tigerbbs.com/0334d7b658efcee4f8a876775ab43fd8","vip":1,"crmLevel":6,"crmLevelSwitch":0,"authorIdStr":"3586987359612845","idStr":"3586987359612845"},"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9077351985","repostId":1167504690,"repostType":4,"repost":{"id":"1167504690","pubTimestamp":1658454795,"share":"https://ttm.financial/m/news/1167504690?lang=&edition=fundamental","pubTime":"2022-07-22 09:53","market":"us","language":"en","title":"5 Top Stocks Cathie Wood Bought This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1167504690","media":"InvestorPlace","summary":"Cathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchase","content":"<html><head></head><body><ul><li>Cathie Wood&#39;s stock purchases have largely outnumbered her sales this week.</li><li>The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).</li><li>Shares of her flagship ETF, the ARK Innovation ETF(ARKK), are down over 45% year-to-date.</li></ul>Shares of Cathie Wood’s flagship exchange-traded fund (ETF), the ARK Innovation ETF(NYSEARCA:ARKK), are up about 20% the past month. Despite the short term recovery, the ETF is still down more than 45% year-to-date. Cathie Wood stocks haven’t exactly beaten the market so far this year.In related news, the ARK Transparency ETF(BATS:CTRU) will officially be shutting down just eight months after its launch. However, the termination of the fund is not related to performance or a lack of popularity. Rather, the index that CTRU tracks, The Transparency Index, will cease to calculate performance at the end of the month. Ark Investstated that it had failed to find an alternative index to track. CTRU will close on July 26, or “as soon as practical thereafter.” This will be Ark’s first ever fund-closure.With that in mind, let’s take a look at five stocks that Cathie Wood bought this week.5 Top Stocks Cathie Wood Bought This Week1.Kratos Defense &amp; Security Solutions(KTOS)Kratos(NASDAQ:KTOS) operates as a national security company that develops weapons and communication and cybersecurity services for the U.S. and its allies. Unlike many other companies who are cutting their workforce, Kratos recently announced additional job openings at its facility in Birmingham, Alabama. The company also announced that it will invest $8.6 million at its Birmingham facility over the next five years. This investment will support advancements in hypersonic technology.From July 18 to July 20, Wood purchased219,011 shares of KTOS through two of her ETFs. After the purchases, Ark Invest now owns a total of 9.96 million shares.2.Teradyne(TER)Teradyne(NASDAQ:TER) is an automatic test equipment designer that serves customers such as Intel(NASDAQ:INTC) and Qualcomm(NASDAQ:QCOM). The company helps customers automate two key aspects of manufacturing: task automation and electronic testing. The company’s task automation process utilizes collaborative robots to help automate tasks and deliver a fast return on investment (ROI). The electronics testing process helps companies reduce the time-to-market for products using automated test equipment (ATE).From July 18 to July 20, Wood purchased53,822 shares of TER through two of her ETFs. Ark Invest now owns a total of 497,048 shares.3. Ginkgo Bioworks(DNA)Ginkgo Bioworks(NYSE:DNA) is one of the few companies that Wood has been relentlessly buying through ARKK and the ARK Genomic Revolution ETF(BATS:ARKG). On July 18, the two ETFs scooped up a total of1.15 million shares. After the purchases, Ark Invest owns a total of 86.41 million shares, making it a top ten shareholder. Across all Ark ETFs, DNA is currently the 19th largest position with a 1.63% allocation.Ginkgo is a biotech company that specializes in genetic engineering. The company is involved with programming cells in a multitude of industries, ranging from food to therapeutics. This week, Ginkgo announced acollaborationwithSumitomoChemicals, a leading chemical company in Japan. Sumitomo will leverage Ginkgo’s engineering expertise and codebase to help improve products in several industries, such as the beauty and personal care industry.4.Trimble(TRMB)Trimble(NASDAQ:TRMB) provides software and hardware solutions across a variety of industries. The company employs workers in over 40 countries, while its solutions are used in over 150 countries. Additionally, TRMB carries an average price target of $88.29among seven firms with coverage of the stock. This implies upside of more than 35% from current price levels.From July 18 to July 20, Ark Invest purchased 70,734 shares of TRMB through two of its ETFs. This marks a major shift in trend, as Ark only sold shares of Trimble between Dec. 27 and May 2. After the purchases, Ark owns a total of 2.22 million shares.5. Twist Bioscience(TWST)Twist Bioscience(NASDAQ:TWST) is a DNA synthesis company that offers DNA products to customers in several industries. The company developed a proprietary synthetic DNA manufacturing process that allows it to “minimize” the chemistry used for DNA synthesis. The miniaturization allows Twist to “reduce the reaction volumes by a factor of 1,000,000 while increasing throughput by a factor of 1,000.” As a result, Twist’s DNA process translates into time and cost savings for its customers.On July 18, ARKK and ARKG purchased a total of 39,624 shares of TWST. After the purchases, Ark now owns a total of 6.59 million shares, making it the second largest shareholder behind FMR.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Top Stocks Cathie Wood Bought This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Top Stocks Cathie Wood Bought This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-07-22 09:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nCathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ...\n\n<a href=\"https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TWST":"Twist Bioscience Corp","TER":"泰瑞达","KTOS":"克瑞拓斯安全防卫","TRMB":"天宝导航","DNA":"Ginkgo Bioworks Holdings Inc."},"source_url":"https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167504690","content_text":"Cathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ARK Innovation ETF(ARKK), are down over 45% year-to-date.Shares of Cathie Wood’s flagship exchange-traded fund (ETF), the ARK Innovation ETF(NYSEARCA:ARKK), are up about 20% the past month. Despite the short term recovery, the ETF is still down more than 45% year-to-date. Cathie Wood stocks haven’t exactly beaten the market so far this year.In related news, the ARK Transparency ETF(BATS:CTRU) will officially be shutting down just eight months after its launch. However, the termination of the fund is not related to performance or a lack of popularity. Rather, the index that CTRU tracks, The Transparency Index, will cease to calculate performance at the end of the month. Ark Investstated that it had failed to find an alternative index to track. CTRU will close on July 26, or “as soon as practical thereafter.” This will be Ark’s first ever fund-closure.With that in mind, let’s take a look at five stocks that Cathie Wood bought this week.5 Top Stocks Cathie Wood Bought This Week1.Kratos Defense & Security Solutions(KTOS)Kratos(NASDAQ:KTOS) operates as a national security company that develops weapons and communication and cybersecurity services for the U.S. and its allies. Unlike many other companies who are cutting their workforce, Kratos recently announced additional job openings at its facility in Birmingham, Alabama. The company also announced that it will invest $8.6 million at its Birmingham facility over the next five years. This investment will support advancements in hypersonic technology.From July 18 to July 20, Wood purchased219,011 shares of KTOS through two of her ETFs. After the purchases, Ark Invest now owns a total of 9.96 million shares.2.Teradyne(TER)Teradyne(NASDAQ:TER) is an automatic test equipment designer that serves customers such as Intel(NASDAQ:INTC) and Qualcomm(NASDAQ:QCOM). The company helps customers automate two key aspects of manufacturing: task automation and electronic testing. The company’s task automation process utilizes collaborative robots to help automate tasks and deliver a fast return on investment (ROI). The electronics testing process helps companies reduce the time-to-market for products using automated test equipment (ATE).From July 18 to July 20, Wood purchased53,822 shares of TER through two of her ETFs. Ark Invest now owns a total of 497,048 shares.3. Ginkgo Bioworks(DNA)Ginkgo Bioworks(NYSE:DNA) is one of the few companies that Wood has been relentlessly buying through ARKK and the ARK Genomic Revolution ETF(BATS:ARKG). On July 18, the two ETFs scooped up a total of1.15 million shares. After the purchases, Ark Invest owns a total of 86.41 million shares, making it a top ten shareholder. Across all Ark ETFs, DNA is currently the 19th largest position with a 1.63% allocation.Ginkgo is a biotech company that specializes in genetic engineering. The company is involved with programming cells in a multitude of industries, ranging from food to therapeutics. This week, Ginkgo announced acollaborationwithSumitomoChemicals, a leading chemical company in Japan. Sumitomo will leverage Ginkgo’s engineering expertise and codebase to help improve products in several industries, such as the beauty and personal care industry.4.Trimble(TRMB)Trimble(NASDAQ:TRMB) provides software and hardware solutions across a variety of industries. The company employs workers in over 40 countries, while its solutions are used in over 150 countries. Additionally, TRMB carries an average price target of $88.29among seven firms with coverage of the stock. This implies upside of more than 35% from current price levels.From July 18 to July 20, Ark Invest purchased 70,734 shares of TRMB through two of its ETFs. This marks a major shift in trend, as Ark only sold shares of Trimble between Dec. 27 and May 2. After the purchases, Ark owns a total of 2.22 million shares.5. Twist Bioscience(TWST)Twist Bioscience(NASDAQ:TWST) is a DNA synthesis company that offers DNA products to customers in several industries. The company developed a proprietary synthetic DNA manufacturing process that allows it to “minimize” the chemistry used for DNA synthesis. The miniaturization allows Twist to “reduce the reaction volumes by a factor of 1,000,000 while increasing throughput by a factor of 1,000.” As a result, Twist’s DNA process translates into time and cost savings for its customers.On July 18, ARKK and ARKG purchased a total of 39,624 shares of TWST. After the purchases, Ark now owns a total of 6.59 million shares, making it the second largest shareholder behind FMR.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9077353586,"gmtCreate":1658457240845,"gmtModify":1676536162587,"author":{"id":"3576657479862575","authorId":"3576657479862575","name":"Sonny111","avatar":"https://static.tigerbbs.com/aab4c55c779b68c711655294ed2c91c6","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3576657479862575","idStr":"3576657479862575"},"htmlText":"Expert in selling low and buying high. Hopefully she is right this time.. ha ha😅😅","listText":"Expert in selling low and buying high. Hopefully she is right this time.. ha ha😅😅","text":"Expert in selling low and buying high. Hopefully she is right this time.. ha ha😅😅","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9077353586","repostId":1167504690,"repostType":4,"repost":{"id":"1167504690","pubTimestamp":1658454795,"share":"https://ttm.financial/m/news/1167504690?lang=&edition=fundamental","pubTime":"2022-07-22 09:53","market":"us","language":"en","title":"5 Top Stocks Cathie Wood Bought This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1167504690","media":"InvestorPlace","summary":"Cathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchase","content":"<html><head></head><body><ul><li>Cathie Wood&#39;s stock purchases have largely outnumbered her sales this week.</li><li>The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).</li><li>Shares of her flagship ETF, the ARK Innovation ETF(ARKK), are down over 45% year-to-date.</li></ul>Shares of Cathie Wood’s flagship exchange-traded fund (ETF), the ARK Innovation ETF(NYSEARCA:ARKK), are up about 20% the past month. Despite the short term recovery, the ETF is still down more than 45% year-to-date. Cathie Wood stocks haven’t exactly beaten the market so far this year.In related news, the ARK Transparency ETF(BATS:CTRU) will officially be shutting down just eight months after its launch. However, the termination of the fund is not related to performance or a lack of popularity. Rather, the index that CTRU tracks, The Transparency Index, will cease to calculate performance at the end of the month. Ark Investstated that it had failed to find an alternative index to track. CTRU will close on July 26, or “as soon as practical thereafter.” This will be Ark’s first ever fund-closure.With that in mind, let’s take a look at five stocks that Cathie Wood bought this week.5 Top Stocks Cathie Wood Bought This Week1.Kratos Defense &amp; Security Solutions(KTOS)Kratos(NASDAQ:KTOS) operates as a national security company that develops weapons and communication and cybersecurity services for the U.S. and its allies. Unlike many other companies who are cutting their workforce, Kratos recently announced additional job openings at its facility in Birmingham, Alabama. The company also announced that it will invest $8.6 million at its Birmingham facility over the next five years. This investment will support advancements in hypersonic technology.From July 18 to July 20, Wood purchased219,011 shares of KTOS through two of her ETFs. After the purchases, Ark Invest now owns a total of 9.96 million shares.2.Teradyne(TER)Teradyne(NASDAQ:TER) is an automatic test equipment designer that serves customers such as Intel(NASDAQ:INTC) and Qualcomm(NASDAQ:QCOM). The company helps customers automate two key aspects of manufacturing: task automation and electronic testing. The company’s task automation process utilizes collaborative robots to help automate tasks and deliver a fast return on investment (ROI). The electronics testing process helps companies reduce the time-to-market for products using automated test equipment (ATE).From July 18 to July 20, Wood purchased53,822 shares of TER through two of her ETFs. Ark Invest now owns a total of 497,048 shares.3. Ginkgo Bioworks(DNA)Ginkgo Bioworks(NYSE:DNA) is one of the few companies that Wood has been relentlessly buying through ARKK and the ARK Genomic Revolution ETF(BATS:ARKG). On July 18, the two ETFs scooped up a total of1.15 million shares. After the purchases, Ark Invest owns a total of 86.41 million shares, making it a top ten shareholder. Across all Ark ETFs, DNA is currently the 19th largest position with a 1.63% allocation.Ginkgo is a biotech company that specializes in genetic engineering. The company is involved with programming cells in a multitude of industries, ranging from food to therapeutics. This week, Ginkgo announced acollaborationwithSumitomoChemicals, a leading chemical company in Japan. Sumitomo will leverage Ginkgo’s engineering expertise and codebase to help improve products in several industries, such as the beauty and personal care industry.4.Trimble(TRMB)Trimble(NASDAQ:TRMB) provides software and hardware solutions across a variety of industries. The company employs workers in over 40 countries, while its solutions are used in over 150 countries. Additionally, TRMB carries an average price target of $88.29among seven firms with coverage of the stock. This implies upside of more than 35% from current price levels.From July 18 to July 20, Ark Invest purchased 70,734 shares of TRMB through two of its ETFs. This marks a major shift in trend, as Ark only sold shares of Trimble between Dec. 27 and May 2. After the purchases, Ark owns a total of 2.22 million shares.5. Twist Bioscience(TWST)Twist Bioscience(NASDAQ:TWST) is a DNA synthesis company that offers DNA products to customers in several industries. The company developed a proprietary synthetic DNA manufacturing process that allows it to “minimize” the chemistry used for DNA synthesis. The miniaturization allows Twist to “reduce the reaction volumes by a factor of 1,000,000 while increasing throughput by a factor of 1,000.” As a result, Twist’s DNA process translates into time and cost savings for its customers.On July 18, ARKK and ARKG purchased a total of 39,624 shares of TWST. After the purchases, Ark now owns a total of 6.59 million shares, making it the second largest shareholder behind FMR.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Top Stocks Cathie Wood Bought This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Top Stocks Cathie Wood Bought This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-07-22 09:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nCathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ...\n\n<a href=\"https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TWST":"Twist Bioscience Corp","TER":"泰瑞达","KTOS":"克瑞拓斯安全防卫","TRMB":"天宝导航","DNA":"Ginkgo Bioworks Holdings Inc."},"source_url":"https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167504690","content_text":"Cathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ARK Innovation ETF(ARKK), are down over 45% year-to-date.Shares of Cathie Wood’s flagship exchange-traded fund (ETF), the ARK Innovation ETF(NYSEARCA:ARKK), are up about 20% the past month. Despite the short term recovery, the ETF is still down more than 45% year-to-date. Cathie Wood stocks haven’t exactly beaten the market so far this year.In related news, the ARK Transparency ETF(BATS:CTRU) will officially be shutting down just eight months after its launch. However, the termination of the fund is not related to performance or a lack of popularity. Rather, the index that CTRU tracks, The Transparency Index, will cease to calculate performance at the end of the month. Ark Investstated that it had failed to find an alternative index to track. CTRU will close on July 26, or “as soon as practical thereafter.” This will be Ark’s first ever fund-closure.With that in mind, let’s take a look at five stocks that Cathie Wood bought this week.5 Top Stocks Cathie Wood Bought This Week1.Kratos Defense & Security Solutions(KTOS)Kratos(NASDAQ:KTOS) operates as a national security company that develops weapons and communication and cybersecurity services for the U.S. and its allies. Unlike many other companies who are cutting their workforce, Kratos recently announced additional job openings at its facility in Birmingham, Alabama. The company also announced that it will invest $8.6 million at its Birmingham facility over the next five years. This investment will support advancements in hypersonic technology.From July 18 to July 20, Wood purchased219,011 shares of KTOS through two of her ETFs. After the purchases, Ark Invest now owns a total of 9.96 million shares.2.Teradyne(TER)Teradyne(NASDAQ:TER) is an automatic test equipment designer that serves customers such as Intel(NASDAQ:INTC) and Qualcomm(NASDAQ:QCOM). The company helps customers automate two key aspects of manufacturing: task automation and electronic testing. The company’s task automation process utilizes collaborative robots to help automate tasks and deliver a fast return on investment (ROI). The electronics testing process helps companies reduce the time-to-market for products using automated test equipment (ATE).From July 18 to July 20, Wood purchased53,822 shares of TER through two of her ETFs. Ark Invest now owns a total of 497,048 shares.3. Ginkgo Bioworks(DNA)Ginkgo Bioworks(NYSE:DNA) is one of the few companies that Wood has been relentlessly buying through ARKK and the ARK Genomic Revolution ETF(BATS:ARKG). On July 18, the two ETFs scooped up a total of1.15 million shares. After the purchases, Ark Invest owns a total of 86.41 million shares, making it a top ten shareholder. Across all Ark ETFs, DNA is currently the 19th largest position with a 1.63% allocation.Ginkgo is a biotech company that specializes in genetic engineering. The company is involved with programming cells in a multitude of industries, ranging from food to therapeutics. This week, Ginkgo announced acollaborationwithSumitomoChemicals, a leading chemical company in Japan. Sumitomo will leverage Ginkgo’s engineering expertise and codebase to help improve products in several industries, such as the beauty and personal care industry.4.Trimble(TRMB)Trimble(NASDAQ:TRMB) provides software and hardware solutions across a variety of industries. The company employs workers in over 40 countries, while its solutions are used in over 150 countries. Additionally, TRMB carries an average price target of $88.29among seven firms with coverage of the stock. This implies upside of more than 35% from current price levels.From July 18 to July 20, Ark Invest purchased 70,734 shares of TRMB through two of its ETFs. This marks a major shift in trend, as Ark only sold shares of Trimble between Dec. 27 and May 2. After the purchases, Ark owns a total of 2.22 million shares.5. Twist Bioscience(TWST)Twist Bioscience(NASDAQ:TWST) is a DNA synthesis company that offers DNA products to customers in several industries. The company developed a proprietary synthetic DNA manufacturing process that allows it to “minimize” the chemistry used for DNA synthesis. The miniaturization allows Twist to “reduce the reaction volumes by a factor of 1,000,000 while increasing throughput by a factor of 1,000.” As a result, Twist’s DNA process translates into time and cost savings for its customers.On July 18, ARKK and ARKG purchased a total of 39,624 shares of TWST. After the purchases, Ark now owns a total of 6.59 million shares, making it the second largest shareholder behind FMR.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9077353893,"gmtCreate":1658457206612,"gmtModify":1676536162587,"author":{"id":"3558617926022722","authorId":"3558617926022722","name":"kkennn","avatar":"https://static.tigerbbs.com/cfb6967409b5a69e663a7006e885e221","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3558617926022722","idStr":"3558617926022722"},"htmlText":"Okk","listText":"Okk","text":"Okk","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9077353893","repostId":1167504690,"repostType":4,"repost":{"id":"1167504690","pubTimestamp":1658454795,"share":"https://ttm.financial/m/news/1167504690?lang=&edition=fundamental","pubTime":"2022-07-22 09:53","market":"us","language":"en","title":"5 Top Stocks Cathie Wood Bought This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1167504690","media":"InvestorPlace","summary":"Cathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchase","content":"<html><head></head><body><ul><li>Cathie Wood&#39;s stock purchases have largely outnumbered her sales this week.</li><li>The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).</li><li>Shares of her flagship ETF, the ARK Innovation ETF(ARKK), are down over 45% year-to-date.</li></ul>Shares of Cathie Wood’s flagship exchange-traded fund (ETF), the ARK Innovation ETF(NYSEARCA:ARKK), are up about 20% the past month. Despite the short term recovery, the ETF is still down more than 45% year-to-date. Cathie Wood stocks haven’t exactly beaten the market so far this year.In related news, the ARK Transparency ETF(BATS:CTRU) will officially be shutting down just eight months after its launch. However, the termination of the fund is not related to performance or a lack of popularity. Rather, the index that CTRU tracks, The Transparency Index, will cease to calculate performance at the end of the month. Ark Investstated that it had failed to find an alternative index to track. CTRU will close on July 26, or “as soon as practical thereafter.” This will be Ark’s first ever fund-closure.With that in mind, let’s take a look at five stocks that Cathie Wood bought this week.5 Top Stocks Cathie Wood Bought This Week1.Kratos Defense &amp; Security Solutions(KTOS)Kratos(NASDAQ:KTOS) operates as a national security company that develops weapons and communication and cybersecurity services for the U.S. and its allies. Unlike many other companies who are cutting their workforce, Kratos recently announced additional job openings at its facility in Birmingham, Alabama. The company also announced that it will invest $8.6 million at its Birmingham facility over the next five years. This investment will support advancements in hypersonic technology.From July 18 to July 20, Wood purchased219,011 shares of KTOS through two of her ETFs. After the purchases, Ark Invest now owns a total of 9.96 million shares.2.Teradyne(TER)Teradyne(NASDAQ:TER) is an automatic test equipment designer that serves customers such as Intel(NASDAQ:INTC) and Qualcomm(NASDAQ:QCOM). The company helps customers automate two key aspects of manufacturing: task automation and electronic testing. The company’s task automation process utilizes collaborative robots to help automate tasks and deliver a fast return on investment (ROI). The electronics testing process helps companies reduce the time-to-market for products using automated test equipment (ATE).From July 18 to July 20, Wood purchased53,822 shares of TER through two of her ETFs. Ark Invest now owns a total of 497,048 shares.3. Ginkgo Bioworks(DNA)Ginkgo Bioworks(NYSE:DNA) is one of the few companies that Wood has been relentlessly buying through ARKK and the ARK Genomic Revolution ETF(BATS:ARKG). On July 18, the two ETFs scooped up a total of1.15 million shares. After the purchases, Ark Invest owns a total of 86.41 million shares, making it a top ten shareholder. Across all Ark ETFs, DNA is currently the 19th largest position with a 1.63% allocation.Ginkgo is a biotech company that specializes in genetic engineering. The company is involved with programming cells in a multitude of industries, ranging from food to therapeutics. This week, Ginkgo announced acollaborationwithSumitomoChemicals, a leading chemical company in Japan. Sumitomo will leverage Ginkgo’s engineering expertise and codebase to help improve products in several industries, such as the beauty and personal care industry.4.Trimble(TRMB)Trimble(NASDAQ:TRMB) provides software and hardware solutions across a variety of industries. The company employs workers in over 40 countries, while its solutions are used in over 150 countries. Additionally, TRMB carries an average price target of $88.29among seven firms with coverage of the stock. This implies upside of more than 35% from current price levels.From July 18 to July 20, Ark Invest purchased 70,734 shares of TRMB through two of its ETFs. This marks a major shift in trend, as Ark only sold shares of Trimble between Dec. 27 and May 2. After the purchases, Ark owns a total of 2.22 million shares.5. Twist Bioscience(TWST)Twist Bioscience(NASDAQ:TWST) is a DNA synthesis company that offers DNA products to customers in several industries. The company developed a proprietary synthetic DNA manufacturing process that allows it to “minimize” the chemistry used for DNA synthesis. The miniaturization allows Twist to “reduce the reaction volumes by a factor of 1,000,000 while increasing throughput by a factor of 1,000.” As a result, Twist’s DNA process translates into time and cost savings for its customers.On July 18, ARKK and ARKG purchased a total of 39,624 shares of TWST. After the purchases, Ark now owns a total of 6.59 million shares, making it the second largest shareholder behind FMR.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Top Stocks Cathie Wood Bought This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Top Stocks Cathie Wood Bought This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-07-22 09:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nCathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ...\n\n<a href=\"https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TWST":"Twist Bioscience Corp","TER":"泰瑞达","KTOS":"克瑞拓斯安全防卫","TRMB":"天宝导航","DNA":"Ginkgo Bioworks Holdings Inc."},"source_url":"https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167504690","content_text":"Cathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ARK Innovation ETF(ARKK), are down over 45% year-to-date.Shares of Cathie Wood’s flagship exchange-traded fund (ETF), the ARK Innovation ETF(NYSEARCA:ARKK), are up about 20% the past month. Despite the short term recovery, the ETF is still down more than 45% year-to-date. Cathie Wood stocks haven’t exactly beaten the market so far this year.In related news, the ARK Transparency ETF(BATS:CTRU) will officially be shutting down just eight months after its launch. However, the termination of the fund is not related to performance or a lack of popularity. Rather, the index that CTRU tracks, The Transparency Index, will cease to calculate performance at the end of the month. Ark Investstated that it had failed to find an alternative index to track. CTRU will close on July 26, or “as soon as practical thereafter.” This will be Ark’s first ever fund-closure.With that in mind, let’s take a look at five stocks that Cathie Wood bought this week.5 Top Stocks Cathie Wood Bought This Week1.Kratos Defense & Security Solutions(KTOS)Kratos(NASDAQ:KTOS) operates as a national security company that develops weapons and communication and cybersecurity services for the U.S. and its allies. Unlike many other companies who are cutting their workforce, Kratos recently announced additional job openings at its facility in Birmingham, Alabama. The company also announced that it will invest $8.6 million at its Birmingham facility over the next five years. This investment will support advancements in hypersonic technology.From July 18 to July 20, Wood purchased219,011 shares of KTOS through two of her ETFs. After the purchases, Ark Invest now owns a total of 9.96 million shares.2.Teradyne(TER)Teradyne(NASDAQ:TER) is an automatic test equipment designer that serves customers such as Intel(NASDAQ:INTC) and Qualcomm(NASDAQ:QCOM). The company helps customers automate two key aspects of manufacturing: task automation and electronic testing. The company’s task automation process utilizes collaborative robots to help automate tasks and deliver a fast return on investment (ROI). The electronics testing process helps companies reduce the time-to-market for products using automated test equipment (ATE).From July 18 to July 20, Wood purchased53,822 shares of TER through two of her ETFs. Ark Invest now owns a total of 497,048 shares.3. Ginkgo Bioworks(DNA)Ginkgo Bioworks(NYSE:DNA) is one of the few companies that Wood has been relentlessly buying through ARKK and the ARK Genomic Revolution ETF(BATS:ARKG). On July 18, the two ETFs scooped up a total of1.15 million shares. After the purchases, Ark Invest owns a total of 86.41 million shares, making it a top ten shareholder. Across all Ark ETFs, DNA is currently the 19th largest position with a 1.63% allocation.Ginkgo is a biotech company that specializes in genetic engineering. The company is involved with programming cells in a multitude of industries, ranging from food to therapeutics. This week, Ginkgo announced acollaborationwithSumitomoChemicals, a leading chemical company in Japan. Sumitomo will leverage Ginkgo’s engineering expertise and codebase to help improve products in several industries, such as the beauty and personal care industry.4.Trimble(TRMB)Trimble(NASDAQ:TRMB) provides software and hardware solutions across a variety of industries. The company employs workers in over 40 countries, while its solutions are used in over 150 countries. Additionally, TRMB carries an average price target of $88.29among seven firms with coverage of the stock. This implies upside of more than 35% from current price levels.From July 18 to July 20, Ark Invest purchased 70,734 shares of TRMB through two of its ETFs. This marks a major shift in trend, as Ark only sold shares of Trimble between Dec. 27 and May 2. After the purchases, Ark owns a total of 2.22 million shares.5. Twist Bioscience(TWST)Twist Bioscience(NASDAQ:TWST) is a DNA synthesis company that offers DNA products to customers in several industries. The company developed a proprietary synthetic DNA manufacturing process that allows it to “minimize” the chemistry used for DNA synthesis. The miniaturization allows Twist to “reduce the reaction volumes by a factor of 1,000,000 while increasing throughput by a factor of 1,000.” As a result, Twist’s DNA process translates into time and cost savings for its customers.On July 18, ARKK and ARKG purchased a total of 39,624 shares of TWST. After the purchases, Ark now owns a total of 6.59 million shares, making it the second largest shareholder behind FMR.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9077350728,"gmtCreate":1658457043065,"gmtModify":1676536162554,"author":{"id":"3548631862118033","authorId":"3548631862118033","name":"nummiebuddy","avatar":"https://static.tigerbbs.com/cd82325c82cc22414a36390e243a5cf5","vip":1,"crmLevel":2,"crmLevelSwitch":1,"authorIdStr":"3548631862118033","idStr":"3548631862118033"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9077350728","repostId":1167504690,"repostType":4,"repost":{"id":"1167504690","pubTimestamp":1658454795,"share":"https://ttm.financial/m/news/1167504690?lang=&edition=fundamental","pubTime":"2022-07-22 09:53","market":"us","language":"en","title":"5 Top Stocks Cathie Wood Bought This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1167504690","media":"InvestorPlace","summary":"Cathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchase","content":"<html><head></head><body><ul><li>Cathie Wood&#39;s stock purchases have largely outnumbered her sales this week.</li><li>The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).</li><li>Shares of her flagship ETF, the ARK Innovation ETF(ARKK), are down over 45% year-to-date.</li></ul>Shares of Cathie Wood’s flagship exchange-traded fund (ETF), the ARK Innovation ETF(NYSEARCA:ARKK), are up about 20% the past month. Despite the short term recovery, the ETF is still down more than 45% year-to-date. Cathie Wood stocks haven’t exactly beaten the market so far this year.In related news, the ARK Transparency ETF(BATS:CTRU) will officially be shutting down just eight months after its launch. However, the termination of the fund is not related to performance or a lack of popularity. Rather, the index that CTRU tracks, The Transparency Index, will cease to calculate performance at the end of the month. Ark Investstated that it had failed to find an alternative index to track. CTRU will close on July 26, or “as soon as practical thereafter.” This will be Ark’s first ever fund-closure.With that in mind, let’s take a look at five stocks that Cathie Wood bought this week.5 Top Stocks Cathie Wood Bought This Week1.Kratos Defense &amp; Security Solutions(KTOS)Kratos(NASDAQ:KTOS) operates as a national security company that develops weapons and communication and cybersecurity services for the U.S. and its allies. Unlike many other companies who are cutting their workforce, Kratos recently announced additional job openings at its facility in Birmingham, Alabama. The company also announced that it will invest $8.6 million at its Birmingham facility over the next five years. This investment will support advancements in hypersonic technology.From July 18 to July 20, Wood purchased219,011 shares of KTOS through two of her ETFs. After the purchases, Ark Invest now owns a total of 9.96 million shares.2.Teradyne(TER)Teradyne(NASDAQ:TER) is an automatic test equipment designer that serves customers such as Intel(NASDAQ:INTC) and Qualcomm(NASDAQ:QCOM). The company helps customers automate two key aspects of manufacturing: task automation and electronic testing. The company’s task automation process utilizes collaborative robots to help automate tasks and deliver a fast return on investment (ROI). The electronics testing process helps companies reduce the time-to-market for products using automated test equipment (ATE).From July 18 to July 20, Wood purchased53,822 shares of TER through two of her ETFs. Ark Invest now owns a total of 497,048 shares.3. Ginkgo Bioworks(DNA)Ginkgo Bioworks(NYSE:DNA) is one of the few companies that Wood has been relentlessly buying through ARKK and the ARK Genomic Revolution ETF(BATS:ARKG). On July 18, the two ETFs scooped up a total of1.15 million shares. After the purchases, Ark Invest owns a total of 86.41 million shares, making it a top ten shareholder. Across all Ark ETFs, DNA is currently the 19th largest position with a 1.63% allocation.Ginkgo is a biotech company that specializes in genetic engineering. The company is involved with programming cells in a multitude of industries, ranging from food to therapeutics. This week, Ginkgo announced acollaborationwithSumitomoChemicals, a leading chemical company in Japan. Sumitomo will leverage Ginkgo’s engineering expertise and codebase to help improve products in several industries, such as the beauty and personal care industry.4.Trimble(TRMB)Trimble(NASDAQ:TRMB) provides software and hardware solutions across a variety of industries. The company employs workers in over 40 countries, while its solutions are used in over 150 countries. Additionally, TRMB carries an average price target of $88.29among seven firms with coverage of the stock. This implies upside of more than 35% from current price levels.From July 18 to July 20, Ark Invest purchased 70,734 shares of TRMB through two of its ETFs. This marks a major shift in trend, as Ark only sold shares of Trimble between Dec. 27 and May 2. After the purchases, Ark owns a total of 2.22 million shares.5. Twist Bioscience(TWST)Twist Bioscience(NASDAQ:TWST) is a DNA synthesis company that offers DNA products to customers in several industries. The company developed a proprietary synthetic DNA manufacturing process that allows it to “minimize” the chemistry used for DNA synthesis. The miniaturization allows Twist to “reduce the reaction volumes by a factor of 1,000,000 while increasing throughput by a factor of 1,000.” As a result, Twist’s DNA process translates into time and cost savings for its customers.On July 18, ARKK and ARKG purchased a total of 39,624 shares of TWST. After the purchases, Ark now owns a total of 6.59 million shares, making it the second largest shareholder behind FMR.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Top Stocks Cathie Wood Bought This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Top Stocks Cathie Wood Bought This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-07-22 09:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nCathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ...\n\n<a href=\"https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TWST":"Twist Bioscience Corp","TER":"泰瑞达","KTOS":"克瑞拓斯安全防卫","TRMB":"天宝导航","DNA":"Ginkgo Bioworks Holdings Inc."},"source_url":"https://investorplace.com/2022/07/5-top-stocks-cathie-wood-bought-this-week-2/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167504690","content_text":"Cathie Wood's stock purchases have largely outnumbered her sales this week.The fund manager purchased shares in companies like Ginkgo Bioworks(DNA) and Teradyne(TER).Shares of her flagship ETF, the ARK Innovation ETF(ARKK), are down over 45% year-to-date.Shares of Cathie Wood’s flagship exchange-traded fund (ETF), the ARK Innovation ETF(NYSEARCA:ARKK), are up about 20% the past month. Despite the short term recovery, the ETF is still down more than 45% year-to-date. Cathie Wood stocks haven’t exactly beaten the market so far this year.In related news, the ARK Transparency ETF(BATS:CTRU) will officially be shutting down just eight months after its launch. However, the termination of the fund is not related to performance or a lack of popularity. Rather, the index that CTRU tracks, The Transparency Index, will cease to calculate performance at the end of the month. Ark Investstated that it had failed to find an alternative index to track. CTRU will close on July 26, or “as soon as practical thereafter.” This will be Ark’s first ever fund-closure.With that in mind, let’s take a look at five stocks that Cathie Wood bought this week.5 Top Stocks Cathie Wood Bought This Week1.Kratos Defense & Security Solutions(KTOS)Kratos(NASDAQ:KTOS) operates as a national security company that develops weapons and communication and cybersecurity services for the U.S. and its allies. Unlike many other companies who are cutting their workforce, Kratos recently announced additional job openings at its facility in Birmingham, Alabama. The company also announced that it will invest $8.6 million at its Birmingham facility over the next five years. This investment will support advancements in hypersonic technology.From July 18 to July 20, Wood purchased219,011 shares of KTOS through two of her ETFs. After the purchases, Ark Invest now owns a total of 9.96 million shares.2.Teradyne(TER)Teradyne(NASDAQ:TER) is an automatic test equipment designer that serves customers such as Intel(NASDAQ:INTC) and Qualcomm(NASDAQ:QCOM). The company helps customers automate two key aspects of manufacturing: task automation and electronic testing. The company’s task automation process utilizes collaborative robots to help automate tasks and deliver a fast return on investment (ROI). The electronics testing process helps companies reduce the time-to-market for products using automated test equipment (ATE).From July 18 to July 20, Wood purchased53,822 shares of TER through two of her ETFs. Ark Invest now owns a total of 497,048 shares.3. Ginkgo Bioworks(DNA)Ginkgo Bioworks(NYSE:DNA) is one of the few companies that Wood has been relentlessly buying through ARKK and the ARK Genomic Revolution ETF(BATS:ARKG). On July 18, the two ETFs scooped up a total of1.15 million shares. After the purchases, Ark Invest owns a total of 86.41 million shares, making it a top ten shareholder. Across all Ark ETFs, DNA is currently the 19th largest position with a 1.63% allocation.Ginkgo is a biotech company that specializes in genetic engineering. The company is involved with programming cells in a multitude of industries, ranging from food to therapeutics. This week, Ginkgo announced acollaborationwithSumitomoChemicals, a leading chemical company in Japan. Sumitomo will leverage Ginkgo’s engineering expertise and codebase to help improve products in several industries, such as the beauty and personal care industry.4.Trimble(TRMB)Trimble(NASDAQ:TRMB) provides software and hardware solutions across a variety of industries. The company employs workers in over 40 countries, while its solutions are used in over 150 countries. Additionally, TRMB carries an average price target of $88.29among seven firms with coverage of the stock. This implies upside of more than 35% from current price levels.From July 18 to July 20, Ark Invest purchased 70,734 shares of TRMB through two of its ETFs. This marks a major shift in trend, as Ark only sold shares of Trimble between Dec. 27 and May 2. After the purchases, Ark owns a total of 2.22 million shares.5. Twist Bioscience(TWST)Twist Bioscience(NASDAQ:TWST) is a DNA synthesis company that offers DNA products to customers in several industries. The company developed a proprietary synthetic DNA manufacturing process that allows it to “minimize” the chemistry used for DNA synthesis. The miniaturization allows Twist to “reduce the reaction volumes by a factor of 1,000,000 while increasing throughput by a factor of 1,000.” As a result, Twist’s DNA process translates into time and cost savings for its customers.On July 18, ARKK and ARKG purchased a total of 39,624 shares of TWST. After the purchases, Ark now owns a total of 6.59 million shares, making it the second largest shareholder behind FMR.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":291,"commentSize":60,"repostSize":0,"favoriteSize":2,"likeStatus":false,"favoriteStatus":false}}